_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,orig_e1,orig_e2,expertdecision,relation,sent_id,orig_sentence,term1,term2
502247651,7/11/2014 12:08:57,,1320694882,7/11/2014 12:08:46,prodege,1,15287417,CAN,ON,Mississauga,209.171.47.69,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS poliomyelitis,20-51,103,OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:09:21,,1320695040,7/11/2014 12:09:12,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS,20,103,OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:17:10,,1320698530,7/11/2014 12:16:44,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS,20,103,OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:24:49,,1320701815,7/11/2014 12:24:39,clixsense,1,27812714,NLD,06,Tilburg,84.31.160.155,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS,20,84-88-100-103,the development of OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:26:30,,1320702677,7/11/2014 12:26:07,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,the JOINTS of the affected limb,16-20-27-30-34-43,84-88-100-103,the development of OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:28:08,,1320703864,7/11/2014 12:25:43,gifthulk,1,18659496,CAN,ON,Toronto,198.84.188.216,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,said that the JOINTS of the affected,6-11-16-20-27-30-34,84-88-100-103,the development of OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:28:13,,1320703916,7/11/2014 12:28:03,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS,20,103,OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:33:49,,1320706883,7/11/2014 12:33:31,neodev,1,12115558,USA,OH,Twinsburg,75.187.196.41,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS,20,103,OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:37:26,,1320708756,7/11/2014 12:36:37,instagc,1,18531561,CAN,ON,Mississauga,99.229.185.45,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,JOINTS of the affected limb by poliomyelitis,20-27-30-34-43-51-48,103,OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247651,7/11/2014 12:38:56,,1320709449,7/11/2014 12:38:51,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,20,103,,,26,117,JOINTS,OSTEOARTHRITIS,said that the JOINTS of the affected,6-11-16-20-27-30-34,84-88-100-103,the development of OSTEOARTHRITIS.,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis.,20,103,20,103,26,117,1,RO-disease_has_primary_anatomic_site,902353,It is said that the joints of the affected limb by poliomyelitis are protected from the development of osteoarthritis,joints,osteoarthritis
502247652,7/11/2014 12:08:20,,1320694644,7/11/2014 12:08:05,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:20:42,,1320700015,7/11/2014 12:20:25,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:28:58,,1320704281,7/11/2014 12:28:50,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"Lange syndrome, with SYNOPHRYS, long curly eyelashes",65-71-81-86-97-102-108,39-46-49-53-62-65-71-81-86-97,"facies of the CORNELIA DE LANGE SYNDROME, with synophrys, long","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:36:49,,1320708429,7/11/2014 12:36:19,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:37:57,,1320708959,7/11/2014 12:37:54,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"Lange syndrome, with SYNOPHRYS, long curly eyelashes",65-71-81-86-97-102-108,39-46-49-53-62-65-71-81-86-97,"facies of the CORNELIA DE LANGE SYNDROME, with synophrys, long","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:39:04,,1320709527,7/11/2014 12:38:48,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:46:58,,1320713167,7/11/2014 12:46:33,prizezombie,1,19082757,USA,AL,Birmingham,138.26.153.43,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"Cornelia de Lange syndrome, with SYNOPHRYS, long curly eyelashes",53-65-71-81-86-97-102-108-62,39-46-49-53-62-65-71-81-86-97-102-108,"facies of the CORNELIA DE LANGE SYNDROME, with synophrys, long curly eyelashes","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:48:39,,1320714003,7/11/2014 12:48:09,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:50:34,,1320715191,7/11/2014 12:50:08,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247652,7/11/2014 12:52:39,,1320716334,7/11/2014 12:52:07,instagc,1,13763729,USA,"","",75.182.89.225,86,53,,,95,79,SYNOPHRYS,CORNELIA DE LANGE SYNDROME,"SYNOPHRYS,",86,53-62-65-71,"CORNELIA DE LANGE SYNDROME,","The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly.",86,53 62 65 71,86,53,95,79,1,RO-has_manifestation,906277,"The patients showed the characteristic facies of the Cornelia de Lange syndrome, with synophrys, long curly eyelashes and small upturned nose, and physical features, including generalized hirsutism, monodactyly, syndactyly and clinodactyly",synophrys,Cornelia de Lange syndrome
502247653,7/11/2014 12:03:36,,1320692415,7/11/2014 12:03:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,DIARRHEA,66,125,SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:04:19,,1320692746,7/11/2014 12:03:50,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,DIARRHEA,66,125,SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:09:22,,1320695049,7/11/2014 12:09:10,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,DIARRHEA,66,125,SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:12:51,,1320696656,7/11/2014 12:12:43,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,"diabetes, weight loss, DIARRHEA and steatorrhea, immunohistochemical",43-53-60-66-75-79-92,92-112-122-125-148-156,immunohistochemical diagnosis of SOMATOSTATINOMA biopsy) and,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:16:49,,1320698324,7/11/2014 12:16:34,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,"loss, DIARRHEA",60-66,125,SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:17:36,,1320698705,7/11/2014 12:17:09,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,"DIARRHEA and steatorrhea,",66-79-75,92-112-122-125,immunohistochemical diagnosis of SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:18:40,,1320699125,7/11/2014 12:18:05,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,DIARRHEA,66,92-112-122-125,immunohistochemical diagnosis of SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:23:48,,1320701350,7/11/2014 12:23:35,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,DIARRHEA,66,125,SOMATOSTATINOMA,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:25:08,,1320701940,7/11/2014 12:25:02,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,"diabetes, weight loss, DIARRHEA and steatorrhea, immunohistochemical",43-53-60-66-75-79-92,92-112-122-125-148-156,immunohistochemical diagnosis of SOMATOSTATINOMA biopsy) and,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247653,7/11/2014 12:37:38,,1320708802,7/11/2014 12:37:34,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,66,125,,,74,140,DIARRHEA,SOMATOSTATINOMA,"diabetes, weight loss, DIARRHEA and steatorrhea, immunohistochemical",43-53-60-66-75-79-92,92-112-122-125-148-156,immunohistochemical diagnosis of SOMATOSTATINOMA biopsy) and,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",66,125,66,125,74,140,1,RO-disease_may_have_finding,902928,"A 61-yr-old woman with gallbladder stones, diabetes, weight loss, diarrhea and steatorrhea, immunohistochemical diagnosis of somatostatinoma (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy",diarrhea,somatostatinoma
502247654,7/11/2014 12:07:58,,1320694514,7/11/2014 12:07:24,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267-275,"(ATOPIC dermatitis,","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:08:00,,1320694520,7/11/2014 12:07:39,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267,(ATOPIC,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:16:15,,1320698018,7/11/2014 12:15:38,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267-275-287-296-306-315-331-340-353-356,"(ATOPIC dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma)","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:16:43,,1320698248,7/11/2014 12:16:02,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267,(ATOPIC,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:24:45,,1320701765,7/11/2014 12:24:19,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267-275,"(ATOPIC dermatitis,","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:39:10,,1320709553,7/11/2014 12:38:42,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267-275,"(ATOPIC dermatitis,","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:47:33,,1320713431,7/11/2014 12:47:09,instagc,1,23149109,USA,NC,Cary,24.206.38.18,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,287-296,"allergic rhinitis,","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:50:48,,1320715313,7/11/2014 12:50:19,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,261-267-275-287-296-306-315-331-340-353-356,"atopy (ATOPIC dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma)","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:51:54,,1320715933,7/11/2014 12:51:28,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",287-296,267-275,"(ATOPIC dermatitis,","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247654,7/11/2014 12:52:44,,1320716356,7/11/2014 12:52:30,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,287,268,,,304,274,ALLERGIC RHINITIS,ATOPIC,"Personal or family history of atopy (atopic dermatitis, ALLERGIC RHINITIS, allergic conjunctivitis, allergic",231-240-243-250-261-267-275-287-296-306-315-331-258,231-240-243-258-261-267-275-287-296-250,"Personal or family history of atopy (ATOPIC dermatitis, allergic rhinitis,","Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and.",287 296,,287,268,304,274,-1,RO-cause_of,900072,"Tables  Table 1 - Diagnostic Criteria for Atopic Dermatitis 15  Normal;          Section 2 / Chapter IV - Eczematous Disorders, Atopic Dermatitis, and Ichthyoses Table 1 - Diagnostic Criteria for Atopic Dermatitis15 Major criteria Personal or family history of atopy (atopic dermatitis, allergic rhinitis, allergic conjunctivitis, allergic blepharitis, or asthma) Characteristic morphology and distribution of lesions Pruritus Chronic or chronically recurring dermatosis Minor features Hyperimmunoglobulinemia E Food intolerance Intolerance to wool and lipid solvents Keratosis pilaris (perifollicular papules with keratotic plugs, typically on the arms and",allergic rhinitis,atopic
502247655,7/11/2014 12:08:04,,1320694549,7/11/2014 12:07:53,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA,13-24,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:19:59,,1320699686,7/11/2014 12:19:36,prodege,1.0,6316959,GBR,"","",87.112.13.121,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA,13-24,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:27:13,,1320703278,7/11/2014 12:26:39,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA,13-24,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:33:30,,1320706688,7/11/2014 12:32:53,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA,13-24,47-58-62,acetorphan and OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:35:25,,1320707734,7/11/2014 12:35:04,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA,13-24,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:37:02,,1320708535,7/11/2014 12:36:56,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,Treatment of refractory DIARRHOEA in AIDS with,0-10-13-24-34-37-42,42-47-58-62-74-76-87,with acetorphan and OCTREOTIDE: a randomized crossover,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:38:10,,1320709091,7/11/2014 12:37:49,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA in AIDS,13-24-34-37,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:47:52,,1320713558,7/11/2014 12:46:08,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,Treatment of refractory DIARRHOEA in AIDS with,0-10-13-24-34-37-42,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:49:07,,1320714270,7/11/2014 12:48:43,instagc,1.0,13763729,USA,"","",75.182.89.225,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,DIARRHOEA,24,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247655,7/11/2014 12:49:59,,1320714763,7/11/2014 12:49:28,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,24,62,,,33,72,DIARRHOEA,OCTREOTIDE,refractory DIARRHOEA,13-24,62,OCTREOTIDE:,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.,24,62,24,62,33,72,1,RO-may_treat,907795,Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study,diarrhoea,octreotide
502247656,7/11/2014 12:02:23,,1320691791,7/11/2014 12:02:09,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:05:49,,1320693326,7/11/2014 12:05:25,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:06:38,,1320693854,7/11/2014 12:06:27,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:18:28,,1320699058,7/11/2014 12:18:16,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:24:21,,1320701624,7/11/2014 12:23:59,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:24:59,,1320701880,7/11/2014 12:24:45,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:25:09,,1320701949,7/11/2014 12:24:29,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION ( 77.,42-57-55,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:29:29,,1320704495,7/11/2014 12:29:24,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,may also cure HYPERTENSION 77.,28-32-37-42-57,0-8-11-28-32-37,Removal of PHEOCHROMOCYTOMA may also cure,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:42:35,,1320711067,7/11/2014 12:42:22,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247656,7/11/2014 12:43:40,,1320711675,7/11/2014 12:43:22,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,42,11,,,54,27,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,42,11,PHEOCHROMOCYTOMA,Removal of pheochromocytoma may also cure hypertension ( 77.,42,11,42,11,54,27,-1,RO-disease_may_have_finding,902598,Removal of pheochromocytoma may also cure hypertension ( 77,hypertension,pheochromocytoma
502247657,7/11/2014 12:18:00,,1320698861,7/11/2014 12:17:49,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:29:14,,1320704391,7/11/2014 12:29:10,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"caused by several FUNGI, the most important",25-32-35-43-50-54-59,0-7-18-22-25,FUNGAL INFECTIONS may be caused,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:36:45,,1320708405,7/11/2014 12:36:28,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:37:36,,1320708801,7/11/2014 12:37:18,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:49:47,,1320714630,7/11/2014 12:49:31,instagc,1.0,13763729,USA,"","",75.182.89.225,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:50:18,,1320714946,7/11/2014 12:49:47,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:50:46,,1320715299,7/11/2014 12:50:35,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:51:08,,1320715530,7/11/2014 12:50:55,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"FUNGI,",43,0-7,FUNGAL INFECTIONS,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:54:00,,1320716954,7/11/2014 12:53:41,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"Fungal infections may be caused by several FUNGI, the most important of these being Candida species",0-7-18-22-25-32-35-43-50-54-59-69-72-78-84-92,0-7-18-22-25-32-35-43,"FUNGAL INFECTIONS may be caused by several fungi,","Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247657,7/11/2014 12:55:07,,1320717367,7/11/2014 12:54:45,clixsense,1,17950689,GBR,X5,Cardiff,89.168.38.216,43,0,,,48,17,FUNGI,FUNGAL INFECTIONS,"caused by several FUNGI, the most important",25-32-35-43-50-54-59,0-7-18-22-25,FUNGAL INFECTIONS may be caused,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",43,0 7,43,0,48,17,1,RO-has_causative_agent,903639,"Fungal infections may be caused by several fungi, the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii",fungi,Fungal infections
502247658,7/11/2014 12:07:14,,1320694171,7/11/2014 12:07:04,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:09:37,,1320695134,7/11/2014 12:09:23,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:10:35,,1320695558,7/11/2014 12:10:00,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:15:33,,1320697806,7/11/2014 12:15:11,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:24:35,,1320701725,7/11/2014 12:22:31,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:29:46,,1320704596,7/11/2014 12:29:39,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,43,59,,,53,69,DEPRESSION,IMIPRAMINE,"of the patient's DEPRESSION with imipramine, the",26-29-33-43-54-59-71,33-43-54-59-71-75-83,"patient's depression with IMIPRAMINE, the tremors disappeared,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:37:44,,1320708831,7/11/2014 12:37:30,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:43:21,,1320711471,7/11/2014 12:43:04,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:44:46,,1320712139,7/11/2014 12:44:30,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,43,59,,,53,69,DEPRESSION,IMIPRAMINE,DEPRESSION,43,59,"IMIPRAMINE,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247658,7/11/2014 12:47:14,,1320713269,7/11/2014 12:46:59,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,43,59,,,53,69,DEPRESSION,IMIPRAMINE,"of the patient's DEPRESSION with imipramine, the tremors disappeared,",26-29-33-43-54-59-71-75-83,33-43-54-59-71-75-83,"patient's depression with IMIPRAMINE, the tremors disappeared,","With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression.",43,59,43,59,53,69,1,RO-may_treat,908350,"With successful treatment of the patient's depression with imipramine, the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of depression",depression,imipramine
502247659,7/11/2014 12:05:06,,1320693031,7/11/2014 12:04:46,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,81,57,,,84,66,VZV,VARICELLA,varicella zoster virus (VZV),67-74-80-57,57-67-74,VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:22:23,,1320700752,7/11/2014 12:21:38,prodege,1.0,6316959,GBR,"","",87.112.13.121,81,57,,,84,66,VZV,VARICELLA,varicella zoster virus (VZV),67-74-80-57,57-67-74-80,VARICELLA zoster virus (VZV),"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:28:40,,1320704144,7/11/2014 12:28:26,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,81,57,,,84,66,VZV,VARICELLA,zoster virus (VZV) of the Oka,67-74-80-86-89-93,35-43-48-57-67-74,vaccine live contains VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:30:29,,1320704967,7/11/2014 12:30:19,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,81,57,,,84,66,VZV,VARICELLA,zoster virus,67-74,57-74-67,VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:31:09,,1320705332,7/11/2014 12:30:40,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,81,57,,,84,66,VZV,VARICELLA,zoster virus (VZV),67-74-80,57-67-74,VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:34:43,,1320707406,7/11/2014 12:34:09,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,81,57,,,84,66,VZV,VARICELLA,varicella zoster virus (VZV),57-67-74-80,57-67-74,VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:39:52,,1320709953,7/11/2014 12:39:27,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,81,57,,,84,66,VZV,VARICELLA,varicella zoster virus (VZV),57-67-74-80,57-67-74-80,VARICELLA zoster virus (VZV),"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:41:05,,1320710497,7/11/2014 12:39:53,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,81,57,,,84,66,VZV,VARICELLA,zoster virus (VZV) of the Oka is used to stimulate active immunity to varicella,67-74-80-86-89-93-126-129-134-137-147-154-163-166,35-43-48-57-67-74-126-129-134-137-147-154-163-166,vaccine live contains VARICELLA zoster virus is used to stimulate active immunity to varicella,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:46:57,,1320713155,7/11/2014 12:46:35,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,81,57,,,84,66,VZV,VARICELLA,zoster virus,67-74,57-67-74,VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247659,7/11/2014 12:50:25,,1320715062,7/11/2014 12:50:10,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,81,57,,,84,66,VZV,VARICELLA,zoster virus (VZV),67-74-80,57-74-67,VARICELLA zoster virus,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox.",,57,81,57,84,66,-1,RO-has_causative_agent,903963,"1 ,   27 ,   137   Varicella virus vaccine live contains varicella zoster virus (VZV) of the Oka/Merck strain  1 ,   27   and is used to stimulate active immunity to varicella (chickenpox",VZV,varicella
502247660,7/11/2014 12:14:48,,1320697530,7/11/2014 12:14:27,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,combined with HYPERTHERMIA,378-387-392,423-426-435-440-455,30 patients with HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:21:37,,1320700406,7/11/2014 12:21:21,prodege,1.0,6316959,GBR,"","",87.112.13.121,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455,HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:23:35,,1320701252,7/11/2014 12:23:19,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455,HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:31:07,,1320705323,7/11/2014 12:30:53,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455,HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:44:04,,1320711841,7/11/2014 12:43:37,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455-465,"HEPATOCELLULAR CARCINOMA (HCC),","The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:44:04,,1320711844,7/11/2014 12:43:41,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA in,392-420,440-455-465,"HEPATOCELLULAR CARCINOMA (HCC),","The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:46:53,,1320713131,7/11/2014 12:46:39,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455,HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:49:31,,1320714483,7/11/2014 12:49:07,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455,HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:52:29,,1320716240,7/11/2014 12:51:57,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with hepatocellular carcinoma,358-362-370-378-387-392-405-410-420-423-426-435-440-455,311-315-324-334-337-348-405-410-423-426-435-440-455-472-474-465,"the arterial injection of anticancer drugs were evaluated 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects","The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247660,7/11/2014 12:53:04,,1320716533,7/11/2014 12:52:39,instagc,1.0,13763729,USA,"","",75.182.89.225,392,440,,,404,464,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,392,440-455,HEPATOCELLULAR CARCINOMA,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",392,440 455,392,440,404,464,1,RO-disease_may_have_finding,902839,"The therapeutic results of Lp-TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM-TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with hyperthermia were evaluated in 30 patients with hepatocellular carcinoma (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma",hyperthermia,hepatocellular carcinoma
502247661,7/11/2014 12:04:01,,1320692603,7/11/2014 12:03:53,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:17:32,,1320698688,7/11/2014 12:17:12,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:21:53,,1320700510,7/11/2014 12:21:40,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:23:19,,1320701134,7/11/2014 12:22:45,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,Salmeterol prevented EXERCISE INDUCED ASTHMA in all 13,0-11-21-30-38-45-48-52,0-11-21-30,SALMETEROL prevented exercise induced,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:24:28,,1320701672,7/11/2014 12:23:57,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:36:36,,1320708346,7/11/2014 12:36:23,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:39:13,,1320709585,7/11/2014 12:38:27,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,"Salmeterol prevented EXERCISE INDUCED ASTHMA in all 13 children studied,",0-11-21-30-38-45-48-52-55-64,0-11-21-30-38,SALMETEROL prevented exercise induced asthma,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:44:19,,1320711934,7/11/2014 12:44:05,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:48:48,,1320714123,7/11/2014 12:48:14,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247661,7/11/2014 12:48:50,,1320714137,7/11/2014 12:48:17,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,21,0,,,44,10,EXERCISE INDUCED ASTHMA,SALMETEROL,EXERCISE INDUCED ASTHMA,21-30-38,0,SALMETEROL,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours.",21 30 38,0,21,0,44,10,1,RO-may_prevent,907104,"Salmeterol prevented exercise induced asthma in all 13 children studied, at 1, 5, and 9 hours",exercise induced asthma,Salmeterol
502247662,7/11/2014 12:04:54,,1320692945,7/11/2014 12:04:20,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER,169,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:10:25,,1320695466,7/11/2014 12:10:08,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER,169,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:14:27,,1320697407,7/11/2014 12:14:12,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER,169,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:30:43,,1320705087,7/11/2014 12:30:19,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER,169,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:43:10,,1320711358,7/11/2014 12:42:55,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER and biliary tract.,169-175-179-187,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:45:55,,1320712592,7/11/2014 12:45:26,instagc,1.0,13763729,USA,"","",75.182.89.225,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER,169,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:49:53,,1320714715,7/11/2014 12:49:33,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER,169,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:53:23,,1320716721,7/11/2014 12:53:09,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,LIVER and biliary tract.,169-175-179-187,60-75,"HEPATOCELLULAR CARCINOMA,","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:53:41,,1320716850,7/11/2014 12:53:10,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,diseases involving the LIVER and biliary tract.,146-155-165-169-175-179-187,0-11-20-26-28-32-34-38-43-50-57-60-75-86-89-93-41,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA, it may possibly","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247662,7/11/2014 12:55:13,,1320717433,7/11/2014 12:55:08,clixsense,1.0,17950689,GBR,X5,Cardiff,89.168.38.216,169,60,,,174,84,LIVER,HEPATOCELLULAR CARCINOMA,diseases involving the LIVER and biliary tract.,146-155-165-169-175-179-187,43-50-57-60-75-86-89-93,"useful marker in HEPATOCELLULAR CARCINOMA, it may possibly","Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract.",169,60 75,169,60,174,84,1,RO-disease_has_primary_anatomic_site,902330,"Therefore, although serum P-III-P can be a useful marker in hepatocellular carcinoma, it may possibly be difficult to discriminate it from benign diseases involving the liver and biliary tract",liver,hepatocellular carcinoma
502247663,7/11/2014 12:04:14,,1320692716,7/11/2014 12:04:03,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:06:26,,1320693715,7/11/2014 12:06:12,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS general,220-243,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:14:26,,1320697384,7/11/2014 12:13:48,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,123-125-135-138-148,a diagnosis of BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:16:31,,1320698160,7/11/2014 12:16:17,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:21:02,,1320700170,7/11/2014 12:20:48,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:34:29,,1320707241,7/11/2014 12:34:12,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:40:09,,1320710068,7/11/2014 12:39:29,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:42:03,,1320710797,7/11/2014 12:41:36,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:42:54,,1320711263,7/11/2014 12:42:36,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247663,7/11/2014 12:46:48,,1320713088,7/11/2014 12:45:55,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,220,138,,,230,157,HEMOPTYSIS,BRONCHIAL CARCINOMA,HEMOPTYSIS,220,138-148,BRONCHIAL CARCINOMA,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status.",220,138 148,220,138,230,157,1,RO-disease_may_have_finding,902532,"A chest x-ray showing a large tumor-like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of bronchial carcinoma in a 55-year old, tobacco-smoking Cambodian who consulted for hemoptysis and altered general status",hemoptysis,bronchial carcinoma
502247664,7/11/2014 12:10:56,,1320695703,7/11/2014 12:10:43,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:11:44,,1320696120,7/11/2014 12:11:20,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:15:33,,1320697819,7/11/2014 12:15:01,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,duration of SEIZURES,75-84-87,100-111-114-121,prevention of STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:16:46,,1320698297,7/11/2014 12:16:33,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:34:11,,1320707033,7/11/2014 12:33:55,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:37:29,,1320708796,7/11/2014 12:37:07,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:38:26,,1320709200,7/11/2014 12:38:02,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:39:08,,1320709537,7/11/2014 12:39:02,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,and duration of SEIZURES and prevention of,71-75-84-87-96-100-111,96-100-111-114-121,and prevention of STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:43:01,,1320711311,7/11/2014 12:42:34,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247664,7/11/2014 12:50:35,,1320715199,7/11/2014 12:50:25,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,87,114,,,95,132,SEIZURES,STATUS EPILEPTICUS,SEIZURES,87,114-121,STATUS EPILEPTICUS.,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus.,87,114 121,87,114,95,132,-1,RO-has_definitional_manifestation,904608,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of seizures and prevention of status epilepticus,seizures,status epilepticus
502247665,7/11/2014 12:06:31,,1320693773,7/11/2014 12:06:11,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-167-175,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:08:54,,1320694859,7/11/2014 12:08:36,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,TACHYCARDIA,175,155-164-167,TORSADES DE POINTES,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:10:08,,1320695311,7/11/2014 12:09:50,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,TACHYCARDIA,175,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:18:15,,1320698961,7/11/2014 12:18:01,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-167-175,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:19:05,,1320699279,7/11/2014 12:18:42,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-175-167,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:24:59,,1320701872,7/11/2014 12:24:36,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-167-175,140-152-155-164-167-175,development of TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:37:06,,1320708587,7/11/2014 12:36:35,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-167-175,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:37:40,,1320708810,7/11/2014 12:37:20,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-167-175,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:43:35,,1320711649,7/11/2014 12:43:11,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-175-167,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247665,7/11/2014 12:44:29,,1320712007,7/11/2014 12:44:08,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,175,155,,,186,174,TACHYCARDIA,TORSADES DE POINTES,torsades de pointes TACHYCARDIA,155-164-167-175,155-164-167-175,TORSADES DE POINTES tachycardia,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.,175,155 164 167,175,155,186,174,-1,RO-has_definitional_manifestation,904725,Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage,tachycardia,torsades de pointes
502247666,7/11/2014 12:06:45,,1320693950,7/11/2014 12:06:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,115,ATENOLOL,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:08:42,,1320694787,7/11/2014 12:08:21,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,145,115,,,157,123,HYPERTENSION,ATENOLOL,treatment of HYPERTENSION.,132-145-142,115-124-128-132-145-142,ATENOLOL for the treatment of hypertension.,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:11:54,,1320696214,7/11/2014 12:11:44,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,115,ATENOLOL,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:12:06,,1320696284,7/11/2014 12:11:45,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,115,ATENOLOL,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:15:00,,1320697604,7/11/2014 12:14:18,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,115,ATENOLOL,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:17:01,,1320698422,7/11/2014 12:16:51,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,115,ATENOLOL,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:30:15,,1320704849,7/11/2014 12:30:04,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,145,115,,,157,123,HYPERTENSION,ATENOLOL,the treatment of HYPERTENSION.,128-132-142-145,87-99-111-115-124-128-132,"antagonist, irbesartan, and ATENOLOL for the treatment","Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:31:07,,1320705322,7/11/2014 12:30:44,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,115,ATENOLOL,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:36:44,,1320708400,7/11/2014 12:36:03,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,145,115,,,157,123,HYPERTENSION,ATENOLOL,HYPERTENSION.,145,87-99-111-115,"antagonist, irbesartan, and ATENOLOL","Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247666,7/11/2014 12:39:01,,1320709480,7/11/2014 12:38:57,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,145,115,,,157,123,HYPERTENSION,ATENOLOL,the treatment of HYPERTENSION.,128-132-142-145,87-99-111-115-124-128-132,"antagonist, irbesartan, and ATENOLOL for the treatment","Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension.",145,115,145,115,157,123,1,RO-may_treat,907512,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and atenolol for the treatment of hypertension",hypertension,atenolol
502247667,7/11/2014 12:13:27,,1320696954,7/11/2014 12:13:15,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,symptomatic URINARY TRACT INFECTION,17-29-37-43,90-102,METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:27:24,,1320703420,7/11/2014 12:27:04,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,symptomatic URINARY TRACT INFECTION,17-29-37-43,90-102,METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:29:08,,1320704356,7/11/2014 12:28:59,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,incidence of symptomatic URINARY TRACT INFECTION also decreased during,4-14-17-29-37-43-53-58-68,68-75-85-90-102,during treatment with METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:46:57,,1320713156,7/11/2014 12:46:42,instagc,1.0,13763729,USA,"","",75.182.89.225,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,URINARY TRACT INFECTION,29-37-43,90-102,METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:48:59,,1320714215,7/11/2014 12:48:41,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,URINARY TRACT INFECTION,29-37-43,90-102,METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:51:00,,1320715447,7/11/2014 12:50:48,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,symptomatic URINARY TRACT INFECTION,17-29-37-43,90-102,METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:52:51,,1320716396,7/11/2014 12:51:09,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,URINARY TRACT INFECTION,29-37-43,90-102,METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:53:09,,1320716566,7/11/2014 12:52:45,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,incidence of symptomatic URINARY TRACT INFECTION also decreased during treatment with methenamine hippurate.,4-14-17-29-37-43-53-58-68-75-85-90-102,4-14-17-29-37-43-53-68-75-85-90-102-58,incidence of symptomatic urinary tract infection also decreased during treatment with METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:55:19,,1320717467,7/11/2014 12:55:14,clixsense,1.0,17950689,GBR,X5,Cardiff,89.168.38.216,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,incidence of symptomatic URINARY TRACT INFECTION also decreased during,4-14-17-29-37-43-53-58-68,68-75-85-90-102,during treatment with METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247667,7/11/2014 12:58:33,,1320719041,7/11/2014 12:58:22,fusioncash,1,17395678,USA,OK,Oklahoma City,67.67.9.94,29,90,,,52,111,URINARY TRACT INFECTION,METHENAMINE HIPPURATE,incidence of symptomatic URINARY TRACT INFECTION also decreased during,4-14-17-29-37-43-53-58-68,68-75-85-90-102,during treatment with METHENAMINE HIPPURATE.,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate.,29 37 43,90 102,29,90,52,111,1,RO-may_prevent,907215,The incidence of symptomatic urinary tract infection also decreased during treatment with methenamine hippurate,urinary tract infection,methenamine hippurate
502247668,7/11/2014 12:06:40,,1320693870,7/11/2014 12:06:11,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:11:25,,1320695975,7/11/2014 12:11:11,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:18:03,,1320698863,7/11/2014 12:17:35,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:20:44,,1320700040,7/11/2014 12:20:16,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,21-31-37-40,"causative agent of PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:21:20,,1320700296,7/11/2014 12:20:59,prodege,1.0,6316959,GBR,"","",87.112.13.121,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:21:35,,1320700367,7/11/2014 12:21:21,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:36:02,,1320708083,7/11/2014 12:35:39,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:36:26,,1320708257,7/11/2014 12:36:13,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:45:20,,1320712343,7/11/2014 12:44:21,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS, the causative agent of plague,",0-9-17-21-31-37-40,0-9-17-21-31-37-40-48-52-54-62-65-73-87-98-101-107-112-108,"Yersinia pestis, the causative agent of PLAGUE, has a feature of forming multicellular aggregates at liquid - air interface","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247668,7/11/2014 12:45:24,,1320712373,7/11/2014 12:45:03,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,0,40,,,15,46,YERSINIA PESTIS,PLAGUE,"YERSINIA PESTIS,",0-9,40,"PLAGUE,","Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube.",0 9,40,0,40,15,46,1,RO-has_causative_agent,903744,"Yersinia pestis, the causative agent of plague, has a feature of forming multicellular aggregates at liquid-air interface around the wall of glass tube",Yersinia pestis,plague
502247669,7/11/2014 12:07:52,,1320694462,7/11/2014 12:07:41,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:11:13,,1320695803,7/11/2014 12:11:01,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:19:19,,1320699382,7/11/2014 12:19:05,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:25:41,,1320702181,7/11/2014 12:25:32,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,41,71,,,49,79,SEIZURES,EPILEPSY,treatment can prevent SEIZURES in most persons,19-29-33-41-50-53-58,53-58-66-71-81-86-94,"most persons with EPILEPSY, some persons have","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:32:06,,1320706011,7/11/2014 12:31:39,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:35:43,,1320707920,7/11/2014 12:35:26,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:38:18,,1320709135,7/11/2014 12:38:14,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,41,71,,,49,79,SEIZURES,EPILEPSY,treatment can prevent SEIZURES in most persons,19-29-33-41-50-53-58,53-58-66-71-81-86-94,"most persons with EPILEPSY, some persons have","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:39:43,,1320709869,7/11/2014 12:39:20,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:40:32,,1320710252,7/11/2014 12:40:15,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,41,71,,,49,79,SEIZURES,EPILEPSY,SEIZURES,41,71,"EPILEPSY,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247669,7/11/2014 12:47:31,,1320713422,7/11/2014 12:47:15,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,41,71,,,49,79,SEIZURES,EPILEPSY,"treatment can prevent SEIZURES in most persons with epilepsy, some persons have frequent seizures,",19-29-33-41-50-53-58-66-71-81-86-94-99-108,53-58-66-71-81-86-94-99-108,"most persons with EPILEPSY, some persons have frequent seizures,","Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3.",41,71,41,71,49,79,-1,RO-has_definitional_manifestation,904755,"Although effective treatment can prevent seizures in most persons with epilepsy, some persons have frequent seizures, which can lead to brain damage, disability, and diminished quality of life (2,3",seizures,epilepsy
502247670,7/11/2014 12:19:54,,1320699629,7/11/2014 12:19:35,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,diagnostic test for MYASTHENIA GRAVIS.,193-204-209-213-224,155-167-179,intravenous EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:22:47,,1320700916,7/11/2014 12:22:36,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,155-167-179,intravenous EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:23:56,,1320701443,7/11/2014 12:21:36,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,155-167-179,intravenous EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:27:03,,1320703135,7/11/2014 12:25:42,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,155-167-179,intravenous EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:28:31,,1320704008,7/11/2014 12:28:14,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,155-167-179,intravenous EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:30:32,,1320705013,7/11/2014 12:30:25,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,diagnostic test for MYASTHENIA GRAVIS.,193-204-209-213-224,145-149-155-167-179-188-191-193,and after intravenous EDROPHONIUM CHLORIDE as a diagnostic,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:46:41,,1320713019,7/11/2014 12:46:19,instagc,1.0,13763729,USA,"","",75.182.89.225,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,167-179,EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:47:08,,1320713212,7/11/2014 12:46:54,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,167-179,EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:47:25,,1320713368,7/11/2014 12:47:12,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,167-179,EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247670,7/11/2014 12:47:53,,1320713564,7/11/2014 12:47:34,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,213,167,,,230,187,MYASTHENIA GRAVIS,EDROPHONIUM CHLORIDE,MYASTHENIA GRAVIS.,213-224,155-167-179,intravenous EDROPHONIUM CHLORIDE,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis.,213 224,167 179,213,167,230,187,1,RO-may_diagnose,906834,Maximum velocity and amplitude of repetitive ( 1-per-second) 30 degrees saccadic eye movements were quantitatively assessed for 4 minutes before and after intravenous edrophonium chloride as a diagnostic test for myasthenia gravis,myasthenia gravis,edrophonium chloride
502247671,7/11/2014 12:11:31,,1320696010,7/11/2014 12:11:14,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"ASSOCIATION thrombocytopenia,",18-33,14-18-30-33-51-60,"the association of THROMBOCYTOPENIA, platelet autoantibodies","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:12:06,,1320696289,7/11/2014 12:11:13,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"ASSOCIATION of thrombocytopenia,",18-30-33,33-51-60,"THROMBOCYTOPENIA, platelet autoantibodies","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:12:07,,1320696295,7/11/2014 12:11:56,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,ASSOCIATION,18,33,"THROMBOCYTOPENIA,","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:15:01,,1320697596,7/11/2014 12:14:48,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"ASSOCIATION of thrombocytopenia, platelet",18-30-33-51,14-18-30-33-51-60-75,"the association of THROMBOCYTOPENIA, platelet autoantibodies and","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:22:35,,1320700834,7/11/2014 12:21:54,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"ASSOCIATION of thrombocytopenia,",18-30-33,18-30-33,"association of THROMBOCYTOPENIA,","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:45:29,,1320712408,7/11/2014 12:44:53,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"the ASSOCIATION of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities",18-30-33-51-60-75-79-91-14,33,"THROMBOCYTOPENIA,","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:52:06,,1320716036,7/11/2014 12:51:42,instagc,1.0,13763729,USA,"","",75.182.89.225,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,ASSOCIATION,18,33,"THROMBOCYTOPENIA,","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:52:44,,1320716361,7/11/2014 12:52:31,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,ASSOCIATION,18,33,"THROMBOCYTOPENIA,","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:53:08,,1320716568,7/11/2014 12:52:52,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"ASSOCIATION of thrombocytopenia,",18-30-33,18-30-33,"association of THROMBOCYTOPENIA,","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247671,7/11/2014 12:55:27,,1320717501,7/11/2014 12:55:21,clixsense,1.0,17950689,GBR,X5,Cardiff,89.168.38.216,18,33,,,29,49,ASSOCIATION,THROMBOCYTOPENIA,"nature of the ASSOCIATION of thrombocytopenia, platelet",4-11-14-18-30-33-51,14-18-30-33-51-60-75,"the association of THROMBOCYTOPENIA, platelet autoantibodies and","The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful.",18,33,18,33,29,49,-1,RO-has_definitional_manifestation,904520,"The nature of the association of thrombocytopenia, platelet autoantibodies and chromosomal abnormalities in this family remains doubtful",association,thrombocytopenia
502247672,7/11/2014 12:09:36,,1320695135,7/11/2014 12:09:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181,CEFACLOR,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:11:01,,1320695728,7/11/2014 12:10:49,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181-193-204-206,CEFACLOR penicillin V potassium,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:12:42,,1320696603,7/11/2014 12:12:30,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181,CEFACLOR,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:14:25,,1320697380,7/11/2014 12:12:46,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181,CEFACLOR,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:21:49,,1320700481,7/11/2014 12:19:10,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,144,181,,,155,189,PHARYNGITIS,CEFACLOR,weeks; patients with PHARYNGITIS received 20 mg,123-130-139-144-156-165-168,171-174-178-181-190-193-204,kg day of CEFACLOR or penicillin V,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:35:31,,1320707765,7/11/2014 12:35:03,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181,CEFACLOR,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:38:14,,1320709113,7/11/2014 12:38:09,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,144,181,,,155,189,PHARYNGITIS,CEFACLOR,weeks; patients with PHARYNGITIS received 20 mg,123-130-139-144-156-165-168,171-174-178-181-190-193-204,kg day of CEFACLOR or penicillin V,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:39:58,,1320710022,7/11/2014 12:39:31,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181,CEFACLOR,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:52:29,,1320716241,7/11/2014 12:52:15,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,144,181,,,155,189,PHARYNGITIS,CEFACLOR,PHARYNGITIS,144,181,CEFACLOR,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247672,7/11/2014 12:54:36,,1320717195,7/11/2014 12:54:25,clixsense,1.0,17950689,GBR,X5,Cardiff,89.168.38.216,144,181,,,155,189,PHARYNGITIS,CEFACLOR,weeks; patients with PHARYNGITIS received 20 mg,123-130-139-144-156-165-168,171-174-178-181-190-193-204,kg day of CEFACLOR or penicillin V,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days.,144,181,144,181,155,189,1,RO-may_treat,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days,pharyngitis,cefaclor
502247673,7/11/2014 12:03:06,,1320692134,7/11/2014 12:02:39,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,107-114-124-131,doctor diagnosed ATOPIC diseases,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:03:49,,1320692505,7/11/2014 12:03:09,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,124,ATOPIC,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:12:18,,1320696402,7/11/2014 12:11:59,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,"(hay fever, asthma, ATOPIC DERMATITIS)",140-145-152-160-167,124-131-140-145-152-160-167,"ATOPIC diseases (hay fever, asthma, atopic dermatitis)","Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:21:51,,1320700483,7/11/2014 12:21:37,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,124-131,ATOPIC diseases,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:23:03,,1320701022,7/11/2014 12:22:49,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,124-131,ATOPIC diseases,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:24:55,,1320701853,7/11/2014 12:24:43,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,"(hay fever, asthma, ATOPIC DERMATITIS) in the study",140-145-152-160-167-179-182-186,104-107-114-124-131-145,"of doctor diagnosed ATOPIC diseases fever,","Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:37:48,,1320708853,7/11/2014 12:37:10,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,124-131,ATOPIC diseases,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:43:48,,1320711764,7/11/2014 12:43:36,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,"(hay fever, asthma, ATOPIC DERMATITIS)",140-145-152-160-167,124-131,ATOPIC diseases,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:48:16,,1320713765,7/11/2014 12:47:53,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,124-131,ATOPIC diseases,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247673,7/11/2014 12:48:23,,1320713805,7/11/2014 12:47:57,instagc,1.0,13763729,USA,"","",75.182.89.225,160,124,,,177,130,ATOPIC DERMATITIS,ATOPIC,ATOPIC DERMATITIS),160-167,124,ATOPIC,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets.",160 167,124,160,124,177,130,-1,RO-cause_of,900308,"Using standardised computer-assisted face-to-face interviews, we determined and compared the prevalence of doctor-diagnosed atopic diseases (hay fever, asthma, atopic dermatitis) in the study subjects and veterinarian-diagnosed allergies in their pets",atopic dermatitis,atopic
502247674,7/11/2014 12:13:14,,1320696875,7/11/2014 12:13:01,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"urethral, or rectal GONORRHEA,",41-51-54-61,97-100-112-115-120,IM CEFTRIAXONE or oral cefixime;,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:17:51,,1320698805,7/11/2014 12:17:20,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"rectal GONORRHEA,",54-61,97-100,IM CEFTRIAXONE,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:24:42,,1320701763,7/11/2014 12:24:38,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"urethral, or rectal GONORRHEA, CDC and others",41-51-54-61-72-76-80,80-87-97-100-112-115-120,others recommend IM CEFTRIAXONE or oral cefixime;,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:26:18,,1320702563,7/11/2014 12:26:05,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"rectal GONORRHEA,",54-61,97-100,IM CEFTRIAXONE,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:39:52,,1320709954,7/11/2014 12:39:15,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"urethral, or rectal GONORRHEA, CDC and others is drug of choice for pharyngeal infections.",41-51-54-61-72-76-80-145-148-153-156-163-167-178,80-87-97-100-112-115-120-145-148-153-156-163-167-178,others recommend IM CEFTRIAXONE or oral cefixime; is drug of choice for pharyngeal infections.,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:41:01,,1320710445,7/11/2014 12:40:16,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"cervical, urethral, or rectal GONORRHEA,",31-41-51-54-61,100-97,IM CEFTRIAXONE,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:41:21,,1320710586,7/11/2014 12:39:44,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"rectal GONORRHEA,",54-61,97-100-112-115-120,IM CEFTRIAXONE or oral cefixime;,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:42:51,,1320711243,7/11/2014 12:42:27,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"rectal GONORRHEA,",54-61,97-100,IM CEFTRIAXONE,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:43:36,,1320711652,7/11/2014 12:43:19,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"rectal GONORRHEA,",54-61,97-100,IM CEFTRIAXONE,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247674,7/11/2014 12:45:25,,1320712398,7/11/2014 12:43:54,instagc,1.0,13763729,USA,"","",75.182.89.225,61,100,,,70,111,GONORRHEA,CEFTRIAXONE,"cervical, urethral, or rectal GONORRHEA,",31-41-51-54-61,100-97,IM CEFTRIAXONE,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections.",61,100,61,100,70,111,1,RO-may_treat,907845,"For treatment of uncomplicated cervical, urethral, or rectal gonorrhea, CDC and others recommend IM ceftriaxone or oral cefixime; IM ceftriaxone is drug of choice for pharyngeal infections",gonorrhea,ceftriaxone
502247675,7/11/2014 12:10:41,,1320695601,7/11/2014 12:10:30,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"AGALACTIAE),",161,49-55,GROUP B,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:13:46,,1320697120,7/11/2014 12:13:21,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"streptococcus (STREPTOCOCCUS AGALACTIAE),",132-146-161,38-46-49-55-57-71,history of GROUP B streptococcal infections,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:19:35,,1320699498,7/11/2014 12:19:20,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"(STREPTOCOCCUS AGALACTIAE),",146-161,49-55-57-71,GROUP B streptococcal infections,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:19:44,,1320699557,7/11/2014 12:19:29,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"B streptococcus (STREPTOCOCCUS AGALACTIAE),",130-132-146-161,49-55-57,GROUP B streptococcal,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:29:38,,1320704545,7/11/2014 12:28:27,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"(STREPTOCOCCUS AGALACTIAE),",161-146,49-55-57-71,GROUP B streptococcal infections,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:30:03,,1320704764,7/11/2014 12:29:56,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"B streptococcus (STREPTOCOCCUS AGALACTIAE), an opportunistic pathogen",130-132-146-161-174-177-191,34-38-46-49-55-57-71-82,the history of GROUP B streptococcal infections and,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:38:28,,1320709205,7/11/2014 12:38:24,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"B streptococcus (STREPTOCOCCUS AGALACTIAE), an opportunistic pathogen",130-132-146-161-174-177-191,34-38-46-49-55-57-71-82,the history of GROUP B streptococcal infections and,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:49:25,,1320714421,7/11/2014 12:48:53,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"(STREPTOCOCCUS AGALACTIAE),",146-161,49-55-57-71,GROUP B streptococcal infections,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:49:36,,1320714549,7/11/2014 12:49:12,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"B streptococcus (STREPTOCOCCUS AGALACTIAE), an opportunistic pathogen which causes serious infections in newborn infants",130-132-146-161-174-177-191-200-206-213-221-232-235-243,34-38-46-49-55-57-71-82-86-90-101-107-112-115-124-130-132,the history of GROUP B streptococcal infections and the laboratory tests used to identify Group B streptococcus,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247675,7/11/2014 12:52:17,,1320716113,7/11/2014 12:51:49,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,147,49,,,171,56,STREPTOCOCCUS AGALACTIAE,GROUP B,"(STREPTOCOCCUS AGALACTIAE),",146-161,49-55-57-71,GROUP B streptococcal infections,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.",161,49 55,147,49,171,56,-1,RO-has_causative_agent,903802,"A selected review is presented of the history of Group B streptococcal infections and the laboratory tests used to identify Group B streptococcus (Streptococcus agalactiae), an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups",Streptococcus agalactiae,Group B
502247676,7/11/2014 12:04:27,,1320692808,7/11/2014 12:04:16,clixsense,1,27871219,NLD,07,Amsterdam,87.210.207.223,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,BRAIN,87,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:05:22,,1320693133,7/11/2014 12:04:44,instagc,1,19874561,GBR,C3,Saint Ives,80.4.147.13,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,BRAIN traumatic brain injury,87-96-112-106,96-106-112-119,"TRAUMATIC BRAIN INJURY (TBI),","To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:09:27,,1320695080,7/11/2014 12:09:07,prodege,1,15287417,CAN,ON,Mississauga,209.171.47.69,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,"BRAIN traumatic brain injury (TBI),",87-96-106-112-119,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:09:49,,1320695200,7/11/2014 12:09:38,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,BRAIN,87,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:19:35,,1320699482,7/11/2014 12:19:10,sendearnings,1,11896941,USA,FL,Seminole,97.106.105.251,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,of the aged BRAIN,75-78-82-87,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:21:23,,1320700330,7/11/2014 12:21:08,prodege,1,19192508,USA,OK,Broken Arrow,70.177.111.89,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,aged BRAIN,82-87,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:22:45,,1320700893,7/11/2014 12:22:24,prodege,1,6316959,GBR,"","",87.112.13.121,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,BRAIN,87,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:30:40,,1320705056,7/11/2014 12:30:19,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.197,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,BRAIN,87,96-106-112,TRAUMATIC BRAIN INJURY,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:35:55,,1320708035,7/11/2014 12:35:34,fepcrowdflower,1,17940235,GBR,X5,Cardiff,176.252.22.6,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,BRAIN,87,96-106-112-119,"TRAUMATIC BRAIN INJURY (TBI),","To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247676,7/11/2014 12:37:17,,1320708654,7/11/2014 12:37:12,inboxpounds,1,26876927,GBR,H9,London,81.105.192.192,87,96,,,92,118,BRAIN,TRAUMATIC BRAIN INJURY,of the aged BRAIN to traumatic brain,75-78-82-87-93-96-106,82-87-93-96-106-112-126-129,aged brain to TRAUMATIC BRAIN INJURY we compared,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI.",87,96 106 112,87,96,92,118,1,RO-disease_has_primary_anatomic_site,902145,"To explore the molecular mechanisms underlying the increased vulnerability of the aged brain to traumatic brain injury (TBI), we compared the expression of several age-related genes in the CA1, CA3 and dentate gyrus subfields of the young and aged rat hippocampus before and after lateral fluid percussion TBI",brain,traumatic brain injury
502247677,7/11/2014 12:09:38,,1320695144,7/11/2014 12:09:28,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,RIBOFLAVIN DEFICIENCY,36-47,139,RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:12:29,,1320696485,7/11/2014 12:12:07,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,RIBOFLAVIN DEFICIENCY,36-47,139,RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:17:49,,1320698793,7/11/2014 12:17:28,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,RIBOFLAVIN DEFICIENCY,36-47,139,RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:18:04,,1320698877,7/11/2014 12:17:51,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,subclinical RIBOFLAVIN DEFICIENCY in,24-36-47-68,121-129-136-139,dietary intake of RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:23:10,,1320701077,7/11/2014 12:22:46,prodege,1.0,6316959,GBR,"","",87.112.13.121,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,RIBOFLAVIN DEFICIENCY,36-47,139,RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:30:39,,1320705051,7/11/2014 12:30:30,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,subclinical RIBOFLAVIN DEFICIENCY,24-36-47,139,RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:38:03,,1320709018,7/11/2014 12:37:58,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,suggest that subclinical RIBOFLAVIN DEFICIENCY may occur in,11-19-24-36-47-58-62-68,121-129-136-139,dietary intake of RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:42:07,,1320710851,7/11/2014 12:41:53,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,RIBOFLAVIN DEFICIENCY,36-47,139,RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:46:01,,1320712638,7/11/2014 12:45:46,prizezombie,1,19082757,USA,AL,Birmingham,138.26.153.43,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,These data suggest that subclinical RIBOFLAVIN DEFICIENCY may occur in adolescents,0-6-11-19-24-36-47-58-62-68-71,92-103-107-110-121-129-136-139-118,deficiency may be related to dietary intake of RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247677,7/11/2014 12:46:07,,1320712723,7/11/2014 12:45:28,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,36,139,,,57,149,RIBOFLAVIN DEFICIENCY,RIBOFLAVIN,subclinical RIBOFLAVIN DEFICIENCY,24-36-47,121-129-136-139,dietary intake of RIBOFLAVIN.,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin.,36 47,139,36,139,57,149,1,RO-may_prevent,907355,These data suggest that subclinical riboflavin deficiency may occur in adolescents and that deficiency may be related to dietary intake of riboflavin,riboflavin deficiency,riboflavin
502247678,7/11/2014 12:11:12,,1320695793,7/11/2014 12:10:55,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,3-14-31,82-93-110,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:19:29,,1320699439,7/11/2014 12:19:18,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,3-14-31,82-93-110,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:20:05,,1320699738,7/11/2014 12:19:50,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,3-14-31,82-93-110,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:22:14,,1320700700,7/11/2014 12:21:51,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,a Paroxysmal Supraventricular TACHYCARDIAS Used for prevention,0-3-14-31-45-50-54,69-79-82-93-110-131-136,treatment of paroxysmal SUPRAVENTRICULAR TACHYCARDIAS such as,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:25:58,,1320702291,7/11/2014 12:25:11,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,3-14-31,82-93-110,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:31:08,,1320705331,7/11/2014 12:30:41,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,3-14-31,82-93-110,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:39:19,,1320709639,7/11/2014 12:39:16,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,a Paroxysmal Supraventricular TACHYCARDIAS Used for prevention,0-3-14-31-45-50-54,69-79-82-93-110-131-136,treatment of paroxysmal SUPRAVENTRICULAR TACHYCARDIAS such as,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:40:12,,1320710097,7/11/2014 12:39:05,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,14-31-3,82-93-110-123,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS (PSVTs),"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:40:52,,1320710369,7/11/2014 12:40:31,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,Paroxysmal Supraventricular TACHYCARDIAS,3-14-31,82-93-110-123,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS (PSVTs),"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247678,7/11/2014 12:43:16,,1320711439,7/11/2014 12:42:52,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,31,93,,,43,122,TACHYCARDIAS,SUPRAVENTRICULAR TACHYCARDIAS,a Paroxysmal Supraventricular TACHYCARDIAS,0-3-14-31,82-93-110-123,paroxysmal SUPRAVENTRICULAR TACHYCARDIAS (PSVTs),"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter.",31,93 110,31,93,43,122,-1,RO-has_definitional_manifestation,904593,"a  Paroxysmal Supraventricular Tachycardias  Used for prevention and treatment of paroxysmal supraventricular tachycardias (PSVTs) such as paroxysmal atrial tachycardia, paroxysmal AV junctional rhythm, or paroxysmal atrial fibrillation/flutter",Tachycardias,supraventricular tachycardias
502247679,7/11/2014 12:06:55,,1320694027,7/11/2014 12:06:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:10:06,,1320695299,7/11/2014 12:09:58,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:14:43,,1320697513,7/11/2014 12:14:26,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:34:33,,1320707251,7/11/2014 12:33:50,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:37:52,,1320708903,7/11/2014 12:37:40,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:39:26,,1320709707,7/11/2014 12:39:21,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,used to treat RHEUMATOID ARTHRITIS.,50-55-58-64-75,0-13-16-19,AZATHIOPRINE is an immunosuppressive,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:39:28,,1320709711,7/11/2014 12:39:12,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:44:01,,1320711824,7/11/2014 12:43:49,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:48:08,,1320713696,7/11/2014 12:47:54,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247679,7/11/2014 12:50:53,,1320715368,7/11/2014 12:50:41,instagc,1.0,13763729,USA,"","",75.182.89.225,64,0,,,84,12,RHEUMATOID ARTHRITIS,AZATHIOPRINE,RHEUMATOID ARTHRITIS.,64-75,0,AZATHIOPRINE,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis.,64 75,0,64,0,84,12,1,RO-may_treat,908261,Azathioprine is an immunosuppressive drug that is used to treat rheumatoid arthritis,rheumatoid arthritis,Azathioprine
502247680,7/11/2014 12:07:50,,1320694457,7/11/2014 12:07:08,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I,28-37-46-51,57-53,(GA I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:08:56,,1320694874,7/11/2014 12:08:38,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I,28-37-46-51,46-51-53-57,type I (GA I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:10:17,,1320695393,7/11/2014 12:10:06,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I,28-37-46-51,57,I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:19:23,,1320699404,7/11/2014 12:17:55,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,biochemical hallmark of GLUTARIC ACIDURIA TYPE I due to glutaryl CoA dehydrogenase deficiency,4-16-25-28-37-46-51-60-64-67-76-80-94,28-37-46-51-53-57-64-67-76-80-94-60,glutaric aciduria type I (GA I) due to glutaryl CoA dehydrogenase deficiency,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:20:47,,1320700069,7/11/2014 12:20:24,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I,28-37-46-51,28-37-46-51-53-57,glutaric aciduria type I (GA I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:22:18,,1320700731,7/11/2014 12:21:37,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I,28-37-46-51,28-46-51-53-57-37,glutaric aciduria type I (GA I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:25:30,,1320702087,7/11/2014 12:25:09,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,biochemical hallmark of GLUTARIC ACIDURIA TYPE I I) due,4-16-25-28-37-46-51-57-60,46-51-53-57-60-64-67,type I (GA I) due to glutaryl,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:36:22,,1320708239,7/11/2014 12:34:30,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I (GA I),28-37-46-51-53-57,28-37-46-51-53-57-60-64-67-76-80-94,glutaric aciduria type I (GA I) due to glutaryl CoA dehydrogenase deficiency,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:36:33,,1320708327,7/11/2014 12:36:00,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I,28-37-46-51,28-46-51-53-57-37,glutaric aciduria type I (GA I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247680,7/11/2014 12:38:47,,1320709413,7/11/2014 12:38:27,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,28,54,,,52,58,GLUTARIC ACIDURIA TYPE I,GA I,GLUTARIC ACIDURIA TYPE I (GA I),28-37-46-51-53-57,46-51-53-57,type I (GA I),"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids.",28 37 46 51,57,28,54,52,58,-1,RO-has_manifestation,906037,"The biochemical hallmark of glutaric aciduria type I (GA I) due to glutaryl-CoA dehydrogenase deficiency is the accumulation of glutaric acid, and to a lesser degree of 3-hydroxyglutaric and glutaconic acids",glutaric aciduria type I,GA I
502247681,7/11/2014 12:05:18,,1320693097,7/11/2014 12:05:07,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,78,CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:09:40,,1320695153,7/11/2014 12:09:10,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,78,CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:19:49,,1320699599,7/11/2014 12:19:36,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,78,CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:28:48,,1320704208,7/11/2014 12:28:43,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,and perhaps in SCHIZOPHRENIA may be related,110-114-122-125-139-143-146,55-67-75-78-88-91-96,therapeutic effects of CLOZAPINE in this primate,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:31:53,,1320705830,7/11/2014 12:31:10,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,55-67-75-78,therapeutic effects of CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:32:31,,1320706219,7/11/2014 12:32:07,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,78,CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:32:36,,1320706279,7/11/2014 12:32:17,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,78,CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:39:31,,1320709762,7/11/2014 12:39:27,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,and perhaps in SCHIZOPHRENIA may be related,110-114-122-125-139-143-146,55-67-75-78-88-91-96,therapeutic effects of CLOZAPINE in this primate,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:49:12,,1320714298,7/11/2014 12:48:38,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,and perhaps in SCHIZOPHRENIA may be related at least to the restoration of DA tone in the prefrontal cortex.,110-114-122-125-139-143-146-154-157-171-174-178-190-193-196-201-204-208-219,55-67-75-78-88-91-96-104-110-114-122-125-139-143-146-171-174-178-190-193-196-201-204-208-219,therapeutic effects of CLOZAPINE in this primate model and perhaps in schizophrenia may be related to the restoration of DA tone in the prefrontal cortex.,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247681,7/11/2014 12:49:45,,1320714613,7/11/2014 12:49:29,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,125,78,,,138,87,SCHIZOPHRENIA,CLOZAPINE,SCHIZOPHRENIA,125,78,CLOZAPINE,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex.",125,78,125,78,138,87,1,RO-may_treat,908293,"Thus, the present data support the hypothesis that the therapeutic effects of clozapine in this primate model and perhaps in schizophrenia may be related at least in part to the restoration of DA tone in the prefrontal cortex",schizophrenia,clozapine
502247682,7/11/2014 12:04:45,,1320692909,7/11/2014 12:04:29,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:07:25,,1320694291,7/11/2014 12:07:14,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,DRUG,32,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:11:58,,1320696245,7/11/2014 12:11:45,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:30:52,,1320705181,7/11/2014 12:30:41,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:38:13,,1320709114,7/11/2014 12:37:37,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13-24-32-37,ADVERSE DRUG REACTIONS ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:41:36,,1320710670,7/11/2014 12:41:14,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:43:03,,1320711302,7/11/2014 12:42:45,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:44:13,,1320711905,7/11/2014 12:44:02,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,ADVERSE DRUG REACTIONS,24-32-37,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:48:37,,1320714001,7/11/2014 12:47:48,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,"DRUG REACTIONS ADVERSE DRUG REACTIONS Adverse drug reaction is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",8-13-24-32-37-48-56-61-100-103-105-111-116-126-129-139-154-157-167-175-182-187-191-180,0-8-13-24-32-37,ADVERSE DRUG REACTIONS ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247682,7/11/2014 12:50:40,,1320715233,7/11/2014 12:50:22,instagc,1.0,13763729,USA,"","",75.182.89.225,32,0,,,36,22,DRUG,ADVERSE DRUG REACTIONS,DRUG,32,0-8-13,ADVERSE DRUG REACTIONS,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have.",32,0 8 13,32,0,36,22,-1,RO-has_causative_agent,903739,"ADVERSE DRUG REACTIONS  ADVERSE DRUG REACTIONS  Adverse drug reaction (ADR, or adverse drug effect) is a broad term referring to unwanted, uncomfortable, or dangerous effects that a drug may have",DRUG,ADVERSE DRUG REACTIONS
502247683,7/11/2014 12:06:30,,1320693757,7/11/2014 12:05:24,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,"menstrual cycle is altered, FERTILITY is reduced,",9-19-25-28-37-47-50,90-103-107-119-131-135,osteoporosis and ENDOMETRIAL HYPERPLASIA can result.,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:07:07,,1320694128,7/11/2014 12:06:41,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,107-119,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:09:48,,1320695190,7/11/2014 12:09:37,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,107-119,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:17:08,,1320698488,7/11/2014 12:16:48,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,90-107-119-103,osteoporosis and ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:26:04,,1320702402,7/11/2014 12:25:48,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,107-119,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:37:07,,1320708594,7/11/2014 12:37:03,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,"cycle is altered, FERTILITY is reduced, and",19-25-28-37-47-50-59,87-90-103-107-119-131-135,as osteoporosis and ENDOMETRIAL HYPERPLASIA can result.,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:37:49,,1320708855,7/11/2014 12:37:27,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,107-119,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:39:40,,1320709833,7/11/2014 12:37:49,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,107-119,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:42:10,,1320710877,7/11/2014 12:41:47,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, FERTILITY is reduced, and medical conditions can result.",0-5-9-19-25-28-37-47-50-59-63-71-131-135,0-5-9-19-25-87-90-103-107-119-131-135-28,"When the menstrual cycle is altered, as osteoporosis and ENDOMETRIAL HYPERPLASIA can result.","When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247683,7/11/2014 12:50:32,,1320715146,7/11/2014 12:49:59,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,37,107,,,46,130,FERTILITY,ENDOMETRIAL HYPERPLASIA,FERTILITY,37,107-119,ENDOMETRIAL HYPERPLASIA,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result.",37,107 119,37,107,46,130,-1,RO-disease_may_have_finding,902892,"When the menstrual cycle is altered, fertility is reduced, and medical conditions such as osteoporosis and endometrial hyperplasia can result",fertility,endometrial hyperplasia
502247684,7/11/2014 12:09:59,,1320695265,7/11/2014 12:08:18,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,polypoid MASSES with a mixture of juvenile and adenomatous features.,117-126-133-138-140-148-151-160-164-176,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:11:10,,1320695780,7/11/2014 12:10:58,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,MASSES,126,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:18:21,,1320699008,7/11/2014 12:18:05,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,polypoid MASSES,117-126,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:32:52,,1320706388,7/11/2014 12:31:53,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,large polypoid MASSES,111-117-126,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:38:46,,1320709362,7/11/2014 12:38:02,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,polypoid MASSES,117-126,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:39:14,,1320709590,7/11/2014 12:38:47,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,large polypoid MASSES,111-117-126,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:44:01,,1320711825,7/11/2014 12:43:32,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,biopsies showed both adenomatous polyps and large polypoid MASSES with a mixture of juvenile and adenomatous features.,67-76-83-88-100-107-111-117-126-133-138-140-148-151-160-164-176,67-76-83-88-100-107-111-117-126-133-138-140-148-151-160-164-176,biopsies showed both ADENOMATOUS POLYPS and large polypoid masses with a mixture of juvenile and adenomatous features.,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:45:26,,1320712396,7/11/2014 12:42:47,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,and large polypoid MASSES with a mixture,107-111-117-126-133-138-140,67-76-83-88-100-107-111-117,biopsies showed both ADENOMATOUS POLYPS and large polypoid,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:49:32,,1320714486,7/11/2014 12:47:55,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,polypoid MASSES,126-117,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247684,7/11/2014 12:51:41,,1320715819,7/11/2014 12:51:12,instagc,1.0,13763729,USA,"","",75.182.89.225,126,88,,,132,106,MASSES,ADENOMATOUS POLYPS,polypoid MASSES,117-126,88-100,ADENOMATOUS POLYPS,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features.",126,88 100,126,88,132,106,-1,RO-disease_may_have_finding,902522,"Although initial biopsies were diagnosed as juvenile polyps, later biopsies showed both adenomatous polyps and large polypoid masses with a mixture of juvenile and adenomatous features",masses,adenomatous polyps
502247685,7/11/2014 12:10:29,,1320695494,7/11/2014 12:10:04,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,36,"IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:12:18,,1320696385,7/11/2014 12:12:09,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,36,"IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:13:20,,1320696912,7/11/2014 12:12:40,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,10-19-28-36,"lymphoma patients without IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:17:50,,1320698803,7/11/2014 12:17:38,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,10-19-28-36,"lymphoma patients without IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:25:32,,1320702093,7/11/2014 12:25:18,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,36,"IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:36:12,,1320708167,7/11/2014 12:35:56,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,67,36,,,78,41,WEIGHT LOSS,IPSID,"abdominal pain, WEIGHT LOSS, abdominal masses, obstruction, perforation.",51-61-67-74-80-90-98-115,10-19-36,"lymphoma patients IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:41:09,,1320710520,7/11/2014 12:40:52,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,36,"IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:47:22,,1320713309,7/11/2014 12:46:58,instagc,1.0,13763729,USA,"","",75.182.89.225,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,36,"IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:49:28,,1320714445,7/11/2014 12:49:01,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,67,36,,,78,41,WEIGHT LOSS,IPSID,"WEIGHT LOSS,",67-74,10-19-28-36,"lymphoma patients without IPSID,","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247685,7/11/2014 12:50:27,,1320715083,7/11/2014 12:50:13,clixsense,1.0,17950689,GBR,X5,Cardiff,89.168.38.216,67,36,,,78,41,WEIGHT LOSS,IPSID,"had abdominal pain, WEIGHT LOSS, abdominal masses, obstruction,",47-51-61-67-74-80-90-98,10-19-28-36-43-47-51,"lymphoma patients without IPSID, 65% had abdominal","Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation.",67 74,36,67,36,78,41,-1,RO-disease_may_have_finding,902589,"Among the lymphoma patients without IPSID, 65% had abdominal pain, weight loss, abdominal masses, obstruction, and perforation",weight loss,IPSID
502247686,7/11/2014 12:03:07,,1320692149,7/11/2014 12:02:24,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,ALLERGY,36,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:12:42,,1320696597,7/11/2014 12:12:30,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,36-27,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:13:01,,1320696725,7/11/2014 12:12:48,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,ALLERGY,36,72-89-98-103-114,HYPERSENSITIVITY REACTION with paclitaxel treatment.,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:14:11,,1320697312,7/11/2014 12:13:48,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,36-27,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:19:35,,1320699496,7/11/2014 12:19:13,prodege,1.0,6316959,GBR,"","",87.112.13.121,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,27-36,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:20:15,,1320699795,7/11/2014 12:19:55,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY a higher,27-36-53-55,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:21:39,,1320700428,7/11/2014 12:21:24,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,27-36,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:39:27,,1320709705,7/11/2014 12:39:11,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,27-36,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:48:12,,1320713731,7/11/2014 12:47:53,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,27-36,72-89-103-114-98,HYPERSENSITIVITY REACTION with paclitaxel treatment.,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247686,7/11/2014 12:50:54,,1320715391,7/11/2014 12:50:36,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,36,72,,,43,97,ALLERGY,HYPERSENSITIVITY REACTION,beesting ALLERGY,36-27,72-89,HYPERSENSITIVITY REACTION,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment.,36,72 89,36,72,43,97,-1,RO-cause_of,900406,Patients with a history of beesting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment,allergy,hypersensitivity reaction
502247687,7/11/2014 12:10:03,,1320695288,7/11/2014 12:09:41,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:10:47,,1320695624,7/11/2014 12:10:26,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65-79-75,FLUTAMIDE 250 mg,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:15:45,,1320697859,7/11/2014 12:15:32,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:20:53,,1320700128,7/11/2014 12:20:38,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:27:31,,1320703513,7/11/2014 12:27:15,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:30:18,,1320704880,7/11/2014 12:29:38,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:37:43,,1320708818,7/11/2014 12:37:38,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,18 women with HIRSUTISM treated with combination,5-8-14-19-29-37-42,42-54-62-65-75-79-82,combination therapy of FLUTAMIDE 250 mg twice,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:45:02,,1320712265,7/11/2014 12:44:39,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:46:32,,1320712954,7/11/2014 12:46:03,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,18 women with HIRSUTISM treated with combination therapy of Flutamide had a rapid and marked reduction in their hirsutism score.,5-8-14-19-29-37-42-54-62-65-125-129-131-137-141-148-158-161-167-177,42-54-62-65-75-79-82-88-125-129-131-137-141-148-158-161-167-177,combination therapy of FLUTAMIDE 250 mg twice daily had a rapid and marked reduction in their hirsutism score.,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247687,7/11/2014 12:49:30,,1320714477,7/11/2014 12:49:07,instagc,1.0,13763729,USA,"","",75.182.89.225,19,65,,,28,74,HIRSUTISM,FLUTAMIDE,HIRSUTISM,19,65,FLUTAMIDE,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score.,19,65,19,65,28,74,1,RO-may_treat,907497,17of 18 women with hirsutism treated with combination therapy of Flutamide 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their hirsutism score,hirsutism,Flutamide
502247688,7/11/2014 12:14:15,,1320697315,7/11/2014 12:13:30,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,147-155-165-167-173,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:16:13,,1320697979,7/11/2014 12:15:46,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS,147-155-165-167,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:19:11,,1320699301,7/11/2014 12:18:12,prodege,1.0,6316959,GBR,"","",87.112.13.121,167,84,,,172,99,VIRUS,VIRUS INFECTION,hepatitis B VIRUS,155-165-167,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:20:37,,1320699986,7/11/2014 12:20:24,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,155-165-167-173-147,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:22:30,,1320700782,7/11/2014 12:22:19,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,147-155-165-167-173,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:28:17,,1320703936,7/11/2014 12:27:54,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,147-155-165-167-173,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:29:08,,1320704357,7/11/2014 12:28:32,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS,147-155-165-167,84-90,VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:35:34,,1320707781,7/11/2014 12:35:22,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,147-155-165-167-173,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:36:01,,1320708079,7/11/2014 12:35:44,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,147-155-165-167-173,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247688,7/11/2014 12:40:14,,1320710103,7/11/2014 12:39:42,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,167,84,,,172,99,VIRUS,VIRUS INFECTION,chronic hepatitis B VIRUS infections.,147-155-165-167-173,64-72-82-84-90,chronic hepatitis C VIRUS INFECTION,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections.,167,84 90,167,84,172,99,-1,RO-has_causative_agent,903762,Recombinant IFN-alpha is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections,virus,virus infection
502247689,7/11/2014 12:09:11,,1320694958,7/11/2014 12:08:57,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:14:47,,1320697536,7/11/2014 12:14:28,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:15:09,,1320697651,7/11/2014 12:14:44,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:16:49,,1320698337,7/11/2014 12:16:18,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:27:03,,1320703125,7/11/2014 12:25:58,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"rhabdomyosarcoma, neuroblastoma, retinoblastoma, OSTEOSARCOMA, Wilms' tumour, retinoblastoma,",126-144-159-175-189-196-204,121-126-144-159-175-189-196,"NHL, rhabdomyosarcoma, neuroblastoma, RETINOBLASTOMA, osteosarcoma, Wilms' tumour,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:33:36,,1320706735,7/11/2014 12:32:32,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159-175,"RETINOBLASTOMA, osteosarcoma,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:37:28,,1320708770,7/11/2014 12:37:07,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:38:21,,1320709183,7/11/2014 12:37:54,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:41:57,,1320710775,7/11/2014 12:41:34,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"OSTEOSARCOMA,",175,159,"RETINOBLASTOMA,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247689,7/11/2014 12:45:45,,1320712530,7/11/2014 12:45:20,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,175,159,,,187,173,OSTEOSARCOMA,RETINOBLASTOMA,"Diagnosis specific malignancies available for evaluation included rhabdomyosarcoma, neuroblastoma, retinoblastoma, OSTEOSARCOMA, Wilms' tumour, retinoblastoma,",0-10-19-32-42-46-126-144-159-175-189-196-204-57,0-10-19-32-42-46-121-126-144-159-175-189-196-57,"Diagnosis specific malignancies available for evaluation included NHL, rhabdomyosarcoma, neuroblastoma, RETINOBLASTOMA, osteosarcoma, Wilms' tumour,","Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma.",175,159,175,159,187,173,-1,RO-has_manifestation,906321,"Diagnosis-specific malignancies available for evaluation included ALL, acute myeloid leukaemia (AML), Hodgkin's disease, NHL, rhabdomyosarcoma, neuroblastoma, retinoblastoma, osteosarcoma, Wilms' tumour, retinoblastoma, Ewings' sarcoma, central nervous system (CNS) tumours and hepatoblastoma",osteosarcoma,retinoblastoma
502247690,7/11/2014 12:06:11,,1320693565,7/11/2014 12:05:56,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,INFLAMMATION,100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:08:22,,1320694665,7/11/2014 12:08:11,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,INFLAMMATION,100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:10:03,,1320695293,7/11/2014 12:09:49,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:18:45,,1320699152,7/11/2014 12:18:28,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:23:18,,1320701131,7/11/2014 12:23:05,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:35:02,,1320707520,7/11/2014 12:34:44,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:40:19,,1320710155,7/11/2014 12:39:59,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:50:09,,1320714865,7/11/2014 12:49:54,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:51:27,,1320715709,7/11/2014 12:51:14,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,86-100,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247690,7/11/2014 12:51:48,,1320715905,7/11/2014 12:51:26,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,100,50,,,112,70,INFLAMMATION,PREDNISOLONE ACETATE,postoperative INFLAMMATION,100-86,50-63,PREDNISOLONE ACETATE,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis.,100,50 63,100,50,112,70,1,RO-may_treat,907986,Diclofenac sodium was found to be as effective as prednisolone acetate for control of postoperative inflammation and as effective as flurbiprofen for inhibition of intraoperative miosis,inflammation,prednisolone acetate
502247691,7/11/2014 12:07:13,,1320694165,7/11/2014 12:07:01,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125,ADALIMUMAB,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:12:23,,1320696439,7/11/2014 12:12:06,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125-136-139,ADALIMUMAB 40 mg,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:19:02,,1320699249,7/11/2014 12:18:46,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125,ADALIMUMAB,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:19:10,,1320699297,7/11/2014 12:18:42,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125,ADALIMUMAB,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:24:37,,1320701727,7/11/2014 12:24:32,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,86 patients with RHEUMATOID ARTHRITIS in therapy with,71-74-83-88-99-109-112-120,109-112-120-125-136-139-142,in therapy with ADALIMUMAB 40 mg every,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:28:26,,1320703962,7/11/2014 12:27:25,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125,ADALIMUMAB,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:37:27,,1320708759,7/11/2014 12:37:24,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,86 patients with RHEUMATOID ARTHRITIS in therapy with,71-74-83-88-99-109-112-120,109-112-120-125-136-139-142,in therapy with ADALIMUMAB 40 mg every,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:38:42,,1320709330,7/11/2014 12:38:23,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125,ADALIMUMAB,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:40:50,,1320710346,7/11/2014 12:40:37,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,RHEUMATOID ARTHRITIS,88-99,125,ADALIMUMAB,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247691,7/11/2014 12:51:04,,1320715486,7/11/2014 12:50:24,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,88,125,,,108,135,RHEUMATOID ARTHRITIS,ADALIMUMAB,86 patients with RHEUMATOID ARTHRITIS in therapy with adalimumab in a population of patients observed in clinical practice.,71-74-83-88-99-109-112-120-125-199-202-204-215-218-227-236-239-248,109-112-120-125-136-139-142-148-154-185-189-193-199-202-204-215-218-227-236-239-248,in therapy with ADALIMUMAB 40 mg every other week for two years in a population of patients observed in clinical practice.,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice.,88 99,125,88,125,108,135,1,RO-may_treat,908133,The objective of this study is to perform a cost-effective analysis of 86 patients with rheumatoid arthritis in therapy with adalimumab 40 mg every other week and etanercept 50 mg/week for two years in a population of patients observed in clinical practice,rheumatoid arthritis,adalimumab
502247692,7/11/2014 12:04:43,,1320692887,7/11/2014 12:03:28,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,an isolated PAPULE,84-96-87,50-52-62-73,"a pigmented SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:07:38,,1320694348,7/11/2014 12:07:26,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,PAPULE,96,62-73,"SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:12:29,,1320696487,7/11/2014 12:12:19,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,"keratosis, an isolated PAPULE on the forearm,",73-84-87-96-103-106-110,43-50-52-62-73-84-87-96,"nevus, a pigmented SEBORRHEIC KERATOSIS, an isolated papule","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:15:19,,1320697692,7/11/2014 12:14:48,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,PAPULE,96,52-62-73,"pigmented SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:24:18,,1320701592,7/11/2014 12:23:49,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,PAPULE,96,52-62-73,"pigmented SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:25:32,,1320702110,7/11/2014 12:24:59,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,"isolated PAPULE on the forearm,",87-96-103-106-110,52-62-73,"pigmented SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:37:08,,1320708595,7/11/2014 12:35:38,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,"isolated PAPULE on the forearm,",87-96-103-106-110,52-62-73-130,"pigmented SEBORRHEIC KERATOSIS, lesion,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:37:32,,1320708799,7/11/2014 12:37:28,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,"keratosis, an isolated PAPULE on the forearm,",73-84-87-96-103-106-110,43-50-52-62-73-84-87-96,"nevus, a pigmented SEBORRHEIC KERATOSIS, an isolated papule","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:41:31,,1320710640,7/11/2014 12:41:07,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,isolated PAPULE,87-96,52-62-73,"pigmented SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247692,7/11/2014 12:41:56,,1320710772,7/11/2014 12:41:23,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,96,62,,,102,82,PAPULE,SEBORRHEIC KERATOSIS,isolated PAPULE,87-96,52-62-73,"pigmented SEBORRHEIC KERATOSIS,","These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma.",96,62 73,96,62,102,82,-1,RO-disease_may_have_finding,902798,"These skin lesions included an intradermal nevus, a pigmented seborrheic keratosis, an isolated papule on the forearm, a perianal lesion, and an acantholytic acanthoma",papule,seborrheic keratosis
502247693,7/11/2014 12:06:10,,1320693546,7/11/2014 12:05:50,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:08:45,,1320694799,7/11/2014 12:08:36,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:10:29,,1320695492,7/11/2014 12:10:19,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:16:16,,1320698058,7/11/2014 12:15:53,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,relapsing MULTIPLE SCLEROSIS.,40-50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:19:57,,1320699662,7/11/2014 12:19:45,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:25:47,,1320702198,7/11/2014 12:25:33,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:30:24,,1320704934,7/11/2014 12:30:15,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,1a for relapsing MULTIPLE SCLEROSIS.,33-36-40-50-59,0-12-17-28-33-36-40-50,Natalizumab plus INTERFERON BETA 1A for relapsing multiple,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:31:39,,1320705705,7/11/2014 12:31:07,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:43:31,,1320711585,7/11/2014 12:43:09,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,Natalizumab plus interferon beta 1a for relapsing MULTIPLE SCLEROSIS.,0-12-17-33-36-40-50-59-28,0-12-17-28-33-36-40-50-59,Natalizumab plus INTERFERON BETA 1A for relapsing multiple sclerosis.,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247693,7/11/2014 12:51:24,,1320715676,7/11/2014 12:50:51,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,50,17,,,68,35,MULTIPLE SCLEROSIS,INTERFERON BETA-1A,MULTIPLE SCLEROSIS.,50-59,17-28-33,INTERFERON BETA 1A,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.,50 59,17 28 33,50,17,68,35,1,RO-may_treat,907946,Natalizumab plus interferon beta-1a for relapsing multiple sclerosis,multiple sclerosis,interferon beta-1a
502247694,7/11/2014 12:03:22,,1320692293,7/11/2014 12:03:08,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE,58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:08:12,,1320694599,7/11/2014 12:07:51,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE,58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:09:06,,1320694935,7/11/2014 12:08:58,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE,58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:09:57,,1320695277,7/11/2014 12:09:50,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE,58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:37:53,,1320708919,7/11/2014 12:37:48,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,chronic infection with MYCOBACTERIUM LEPRAE leprae.,35-43-53-58-72-83,0-22-25,LEPROSY is caused,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:38:01,,1320708975,7/11/2014 12:37:45,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE,58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:40:52,,1320710368,7/11/2014 12:40:20,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE (M. leprae.,58-72-79-83,0-8,LEPROSY (hanseniasis),Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:43:39,,1320711671,7/11/2014 12:43:18,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,chronic infection with MYCOBACTERIUM LEPRAE,35-43-53-58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:44:20,,1320711943,7/11/2014 12:44:02,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,Leprosy is caused by chronic infection with MYCOBACTERIUM LEPRAE leprae.,0-22-25-35-43-53-58-72-83-32,0-22-25-32-35-43-53-58-72,LEPROSY is caused by chronic infection with Mycobacterium leprae,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247694,7/11/2014 12:47:11,,1320713215,7/11/2014 12:46:58,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,58,0,,,78,7,MYCOBACTERIUM LEPRAE,LEPROSY,MYCOBACTERIUM LEPRAE,58-72,0,LEPROSY,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae.,58 72,0,58,0,78,7,1,RO-has_causative_agent,903986,Leprosy (hanseniasis) is caused by chronic infection with Mycobacterium leprae (M. leprae,Mycobacterium leprae,Leprosy
502247695,7/11/2014 12:07:40,,1320694376,7/11/2014 12:07:15,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:08:37,,1320694755,7/11/2014 12:08:21,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:27:54,,1320703726,7/11/2014 12:27:03,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:39:11,,1320709570,7/11/2014 12:38:47,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:39:14,,1320709599,7/11/2014 12:39:09,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,75,49,,,83,60,BACTERIA,BACTERIURIA,of over 10(3) BACTERIA per ml of,61-64-69-75-84-88-91,30-35-44-49-61-64-69,from patients with BACTERIURIA of over 10(3),Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:41:46,,1320710727,7/11/2014 12:41:06,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,75,49,,,83,60,BACTERIA,BACTERIURIA,Organisms of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,61-64-69-75-84-88-91-94-100-111-114-120-123-130-135-0,30-35-44-49-61-64-69-75-84-88-91-94-100-111-114-120-123-130-135-0,Organisms from patients with BACTERIURIA of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:47:51,,1320713554,7/11/2014 12:47:34,instagc,1.0,23149109,USA,NC,Cary,24.206.38.18,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:51:12,,1320715591,7/11/2014 12:51:02,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:52:51,,1320716395,7/11/2014 12:52:19,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,75,49,,,83,60,BACTERIA,BACTERIURIA,BACTERIA,75,49,BACTERIURIA,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247695,7/11/2014 12:54:43,,1320717220,7/11/2014 12:54:38,clixsense,1.0,17950689,GBR,X5,Cardiff,89.168.38.216,75,49,,,83,60,BACTERIA,BACTERIURIA,of over 10(3) BACTERIA per ml,61-64-69-75-84-88,30-35-44-49-61-64-69,from patients with BACTERIURIA of over 10(3),Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied.,75,49,75,49,83,60,-1,RO-has_causative_agent,903858,Organisms which were isolated from patients with bacteriuria of over 10(3) bacteria per ml of urine regardless of grade of pyuria were studied,bacteria,bacteriuria
502247696,7/11/2014 12:08:10,,1320694577,7/11/2014 12:08:01,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6,FOLIC ACID,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:12:45,,1320696609,7/11/2014 12:12:30,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6,FOLIC ACID,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:17:11,,1320698523,7/11/2014 12:17:02,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6,FOLIC ACID,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:20:37,,1320700005,7/11/2014 12:20:00,prodege,1.0,6316959,GBR,"","",87.112.13.121,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6,FOLIC ACID,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:33:54,,1320706916,7/11/2014 12:33:33,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6-11,FOLIC ACID concentration,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:38:40,,1320709320,7/11/2014 12:38:35,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,the assessment of FOLIC ACID DEFICIENCY.,47-51-62-65-71-76,0-6-11-25-28,FOLIC ACID concentration in RBC,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:40:49,,1320710367,7/11/2014 12:40:33,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6,FOLIC ACID,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:43:17,,1320711441,7/11/2014 12:43:02,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6-11,FOLIC ACID concentration,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:44:50,,1320712171,7/11/2014 12:44:06,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6-11-25-28,FOLIC ACID concentration in RBC,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247696,7/11/2014 12:51:11,,1320715584,7/11/2014 12:50:53,instagc,1.0,13763729,USA,"","",75.182.89.225,65,0,,,86,10,FOLIC ACID DEFICIENCY,FOLIC ACID,FOLIC ACID DEFICIENCY.,65-71-76,0-6,FOLIC ACID,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency.,65 71 76,0 6,65,0,86,10,1,RO-may_prevent,907141,Folic acid concentration in RBC is decisive in the assessment of folic acid deficiency,folic acid deficiency,Folic acid
502247697,7/11/2014 12:06:10,,1320693545,7/11/2014 12:05:55,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,143,162,,,151,172,OVERDOSE,FLUMAZENIL,opioid OVERDOSE;,136-143,162,FLUMAZENIL,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:08:06,,1320694559,7/11/2014 12:07:51,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,143,162,,,151,172,OVERDOSE,FLUMAZENIL,opioid OVERDOSE;,143-136,162,FLUMAZENIL,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:15:52,,1320697883,7/11/2014 12:15:34,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,143,162,,,151,172,OVERDOSE,FLUMAZENIL,opioid OVERDOSE;,136-143,162-173-177-192,FLUMAZENIL for benzodiazepine overdose,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:16:33,,1320698159,7/11/2014 12:16:14,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,143,162,,,151,172,OVERDOSE,FLUMAZENIL,opioid OVERDOSE;,136-143,162,FLUMAZENIL,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:29:37,,1320704544,7/11/2014 12:29:30,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,143,162,,,151,172,OVERDOSE,FLUMAZENIL,for suspected opioid OVERDOSE; consider flumazenil for,122-126-136-143-153-162-173,136-143-153-162-173-177-192,opioid overdose; consider FLUMAZENIL for benzodiazepine overdose,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:35:38,,1320707843,7/11/2014 12:34:34,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,143,162,,,151,172,OVERDOSE,FLUMAZENIL,suspected opioid OVERDOSE;,126-136-143,162-173-177-192,FLUMAZENIL for benzodiazepine overdose,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:41:13,,1320710545,7/11/2014 12:40:53,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,143,162,,,151,172,OVERDOSE,FLUMAZENIL,opioid OVERDOSE;,136-143,162,FLUMAZENIL,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:41:52,,1320710771,7/11/2014 12:41:33,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,143,162,,,151,172,OVERDOSE,FLUMAZENIL,opioid OVERDOSE;,136-143,162,FLUMAZENIL,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:47:48,,1320713516,7/11/2014 12:47:32,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,143,162,,,151,172,OVERDOSE,FLUMAZENIL,for suspected opioid OVERDOSE; consider flumazenil for benzodiazepine overdose Cholinergic,122-126-136-143-153-162-173-177-192-201,136-143-153-162-173-177-192-201,opioid overdose; consider FLUMAZENIL for benzodiazepine overdose Cholinergic,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247697,7/11/2014 12:50:21,,1320715029,7/11/2014 12:49:47,instagc,1.0,13763729,USA,"","",75.182.89.225,143,162,,,151,172,OVERDOSE,FLUMAZENIL,OVERDOSE;,143,162,FLUMAZENIL,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",143,162,143,162,151,172,1,RO-may_treat,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected opioid overdose; consider flumazenil for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG",overdose,flumazenil
502247698,7/11/2014 12:06:35,,1320693810,7/11/2014 12:06:26,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,81,158,,,92,170,ELEVATED BP,HYPERTENSION,ELEVATED BP,81-90,158,HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:07:40,,1320694367,7/11/2014 12:07:24,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,81,158,,,92,170,ELEVATED BP,HYPERTENSION,ELEVATED BP,81-90,158,HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:08:37,,1320694754,7/11/2014 12:08:14,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,81,158,,,92,170,ELEVATED BP,HYPERTENSION,ELEVATED BP,81-90,158,HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:09:50,,1320695204,7/11/2014 12:09:39,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,81,158,,,92,170,ELEVATED BP,HYPERTENSION,ELEVATED BP,81-90,158,HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:10:54,,1320695688,7/11/2014 12:10:37,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,81,158,,,92,170,ELEVATED BP,HYPERTENSION,spontaneously ELEVATED BP,67-81-90,143-149-152-158,types of human HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:37:22,,1320708711,7/11/2014 12:37:18,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,81,158,,,92,170,ELEVATED BP,HYPERTENSION,monkeys with spontaneously ELEVATED BP may be a,54-62-67-81-90-93-97-100,143-149-152-158,types of human HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:38:27,,1320709201,7/11/2014 12:38:10,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,81,158,,,92,170,ELEVATED BP,HYPERTENSION,spontaneously ELEVATED BP,67-81-90,158,HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:47:33,,1320713451,7/11/2014 12:46:49,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,81,158,,,92,170,ELEVATED BP,HYPERTENSION,spontaneously ELEVATED BP,81-90-67,152-158,human HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:51:31,,1320715779,7/11/2014 12:51:05,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,81,158,,,92,170,ELEVATED BP,HYPERTENSION,monkeys with spontaneously ELEVATED BP may be a useful experimental model for human hypertension.,54-62-67-81-90-93-97-100-102-109-122-128-152-158,40-48-54-93-97-100-102-109-122-128-143-149-152-158-132,African green monkeys may be a useful experimental model for particular types of human HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247698,7/11/2014 12:52:13,,1320716099,7/11/2014 12:51:55,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,81,158,,,92,170,ELEVATED BP,HYPERTENSION,spontaneously ELEVATED BP,67-81-90,158-152,human HYPERTENSION.,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension.",81 90,158,81,158,92,170,-1,RO-has_definitional_manifestation,904583,"Taken together, these data suggest that African green monkeys with spontaneously elevated BP may be a useful experimental model for particular types of human hypertension",elevated BP,hypertension
502247699,7/11/2014 12:02:38,,1320691919,7/11/2014 12:02:24,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,106,42,,,113,48,THYROID,GOITER,THYROID,106,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:15:37,,1320697830,7/11/2014 12:15:01,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,106,42,,,113,48,THYROID,GOITER,no THYROID tissue identifiable,103-106-114-121,13-25-34-42,hypothyroid children without GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:16:00,,1320697925,7/11/2014 12:15:36,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,106,42,,,113,48,THYROID,GOITER,THYROID,106,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:20:23,,1320699850,7/11/2014 12:20:11,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,106,42,,,113,48,THYROID,GOITER,THYROID,106,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:20:58,,1320700149,7/11/2014 12:20:39,prodege,1.0,6316959,GBR,"","",87.112.13.121,106,42,,,113,48,THYROID,GOITER,THYROID,106,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:30:18,,1320704881,7/11/2014 12:29:27,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,106,42,,,113,48,THYROID,GOITER,THYROID,106,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:37:07,,1320708588,7/11/2014 12:36:46,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,106,42,,,113,48,THYROID,GOITER,THYROID,106,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:39:38,,1320709813,7/11/2014 12:39:32,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,106,42,,,113,48,THYROID,GOITER,"RAIU low, no THYROID tissue identifiable",93-98-103-106-114-121,13-25-34-42-49-54-62,hypothyroid children without GOITER were divided into,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:42:33,,1320711059,7/11/2014 12:42:04,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,106,42,,,113,48,THYROID,GOITER,THYROID tissue,106-114,42,GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247699,7/11/2014 12:43:17,,1320711443,7/11/2014 12:42:50,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,106,42,,,113,48,THYROID,GOITER,THYROID tissue,106-114,13-25-34-42,hypothyroid children without GOITER,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",106,42,106,42,113,48,1,RO-disease_has_primary_anatomic_site,902026,"Ninety eight hypothyroid children without goiter were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) thyroiditis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU",thyroid,goiter
502247700,7/11/2014 12:05:31,,1320693181,7/11/2014 12:05:19,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:08:18,,1320694641,7/11/2014 12:08:07,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:11:19,,1320695888,7/11/2014 12:10:58,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:12:29,,1320696486,7/11/2014 12:12:19,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:18:41,,1320699126,7/11/2014 12:18:22,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:24:12,,1320701547,7/11/2014 12:24:02,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,233,203,,,244,211,BRADYCARDIA,ATROPINE,or isoproterenol for BRADYCARDIA.,212-215-229-233,168-180-184-203-212-215-229,"hypotension and bradydysrhythmias, ATROPINE or isoproterenol for","Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:26:05,,1320702384,7/11/2014 12:25:48,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:30:39,,1320705043,7/11/2014 12:28:18,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203-212-215,ATROPINE or isoproterenol,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:38:33,,1320709270,7/11/2014 12:38:29,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,233,203,,,244,211,BRADYCARDIA,ATROPINE,or isoproterenol for BRADYCARDIA.,212-215-229-233,168-180-184-203-212-215-229,"hypotension and bradydysrhythmias, ATROPINE or isoproterenol for","Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247700,7/11/2014 12:38:46,,1320709360,7/11/2014 12:38:28,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,233,203,,,244,211,BRADYCARDIA,ATROPINE,BRADYCARDIA.,233,203,ATROPINE,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia.",233,203,233,203,244,211,1,RO-may_treat,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple-dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, atropine or isoproterenol for bradycardia",bradycardia,atropine
502247701,7/11/2014 12:05:55,,1320693391,7/11/2014 12:05:23,prodege,1,15287417,CAN,ON,Mississauga,209.171.47.69,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,96-98,L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:06:47,,1320693996,7/11/2014 12:06:36,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,96-98,L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:15:31,,1320697782,7/11/2014 12:15:20,clixsense,1,26649250,GBR,N7,Epsom,193.117.31.2,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,96-98,L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:17:19,,1320698604,7/11/2014 12:17:05,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,patients with PARKINSON'S DISEASE,37-46-51-63,71-83-91-96-98,chronically treated with L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:24:38,,1320701732,7/11/2014 12:24:22,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,71-83-91-96-98,chronically treated with L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:25:01,,1320701886,7/11/2014 12:24:55,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,of patients with PARKINSON'S DISEASE chronically treated with,34-37-46-51-63-71-83-91,71-83-91-96-98-103-107-112,chronically treated with L DOPA and also occur,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:34:34,,1320707252,7/11/2014 12:34:12,instagc,1,25901556,GBR,C3,Saint Ives,82.9.129.2,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,96-98,L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:35:21,,1320707720,7/11/2014 12:34:57,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,96-98,L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:37:11,,1320708630,7/11/2014 12:37:08,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,of patients with PARKINSON'S DISEASE chronically treated with,34-37-46-51-63-71-83-91,71-83-91-96-98-103-107-112,chronically treated with L DOPA and also occur,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247701,7/11/2014 12:47:52,,1320713559,7/11/2014 12:47:40,superrewards,1,25748885,USA,PA,Bloomsburg,96.243.117.187,51,96,,,70,102,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,51-63,96-98,L DOPA,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment.",51 63,96 98,51,96,70,102,1,RO-may_treat,908224,"Dyskinesias occur in the majority of patients with Parkinson's disease chronically treated with L-DOPA and also occur in several nonhuman primate species after 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and L-DOPA treatment",Parkinson's disease,L-DOPA
502247702,7/11/2014 12:07:22,,1320694254,7/11/2014 12:06:56,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7,ERGONOVINE,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:08:35,,1320694735,7/11/2014 12:08:23,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7,ERGONOVINE,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:20:10,,1320699767,7/11/2014 12:19:58,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7,ERGONOVINE,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:24:21,,1320701620,7/11/2014 12:24:13,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,"a patient with PRINZMETAL ANGINA presented I,",23-25-33-38-49-56-70,0-7-18-23-25,During ERGONOVINE test a patient,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:34:08,,1320707019,7/11/2014 12:33:36,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7,ERGONOVINE,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:35:03,,1320707534,7/11/2014 12:34:34,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7-18,ERGONOVINE test,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:41:32,,1320710641,7/11/2014 12:41:02,prodege,1,1852770,USA,TX,Abilene,76.198.102.54,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7-18,ERGONOVINE test,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:42:21,,1320710953,7/11/2014 12:42:08,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7,ERGONOVINE,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:51:56,,1320715970,7/11/2014 12:51:32,prizezombie,1,19082757,USA,AL,Birmingham,138.26.153.43,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,"a patient with PRINZMETAL ANGINA presented (in I, aVL, V6)",23-25-33-38-49-56-66-70-73-81,0-7-18-23-25-33-38-49-56-66-73-78-81-70,"During ERGONOVINE test a patient with Prinzmetal angina presented (in I, aVL, V3 V6)","During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247702,7/11/2014 12:53:00,,1320716501,7/11/2014 12:52:46,clixsense,1,6344001,AUS,02,Strathfield,60.241.129.81,38,7,,,55,17,PRINZMETAL ANGINA,ERGONOVINE,PRINZMETAL ANGINA,38-49,7-18,ERGONOVINE test,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina.",38 49,7,38,7,55,17,1,RO-may_diagnose,906606,"During Ergonovine-test a patient with Prinzmetal angina presented (in I, aVL, V3-V6) ST downsloping which, after a temporary phase of alternative normalization (AST) beat to beat in V5, progressed to ST upsloping with typical angina",Prinzmetal angina,Ergonovine
502247703,7/11/2014 12:10:57,,1320695709,7/11/2014 12:10:29,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:22:45,,1320700892,7/11/2014 12:22:16,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,difficult to control HYPERTENSION.,173-183-186-194,74-79-82-91-108-114-117,need to consider PHEOCHROMOCYTOMA early in the,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:25:47,,1320702208,7/11/2014 12:25:33,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:38:32,,1320709250,7/11/2014 12:38:15,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:38:45,,1320709346,7/11/2014 12:38:41,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,difficult to control HYPERTENSION.,173-183-186-194,74-79-82-91-108-114-117,need to consider PHEOCHROMOCYTOMA early in the,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:40:30,,1320710232,7/11/2014 12:40:12,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:41:06,,1320710478,7/11/2014 12:40:51,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:48:42,,1320714049,7/11/2014 12:48:24,instagc,1.0,13763729,USA,"","",75.182.89.225,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:50:06,,1320714817,7/11/2014 12:49:55,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION.,194,91,PHEOCHROMOCYTOMA,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247703,7/11/2014 12:50:24,,1320715041,7/11/2014 12:49:54,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,194,91,,,206,107,HYPERTENSION,PHEOCHROMOCYTOMA,hypertensive emergency or difficult to control HYPERTENSION.,147-160-173-183-186-194-170,74-79-82-91-108-114-117-121-134-144-147-160-170-173-183-186-194,need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension.,194,91,194,91,206,107,1,RO-disease_may_have_finding,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider pheochromocytoma early in the differential diagnosis of hypertensive emergency or difficult to control hypertension,hypertension,pheochromocytoma
502247704,7/11/2014 12:07:03,,1320694108,7/11/2014 12:06:52,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN,57-62-45,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:07:23,,1320694263,7/11/2014 12:06:31,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN,45-57-62,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:12:12,,1320696323,7/11/2014 12:11:53,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN,45-57-62,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:29:55,,1320704670,7/11/2014 12:29:47,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,of Escherichia coli ENDOTOXIN ng kg,42-45-57-62-75-78,0-12-16-23,ENDOTOXEMIA was evoked by,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:35:59,,1320708056,7/11/2014 12:35:33,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN,45-57-62,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:37:17,,1320708653,7/11/2014 12:36:45,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN body,45-57-62-81,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:37:47,,1320708849,7/11/2014 12:37:43,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,of Escherichia coli ENDOTOXIN ng kg,42-45-57-62-75-78,0-12-16-23,ENDOTOXEMIA was evoked by,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:38:00,,1320708987,7/11/2014 12:37:50,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN,45-57-62,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:43:08,,1320711341,7/11/2014 12:42:11,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,injection of Escherichia coli ENDOTOXIN ng kg to investigate the early kinetics of cytokine release,32-42-45-57-62-75-78-118-121-133-137-143-152-155-164,0-12-16-23-26-32-42-45-57-62,ENDOTOXEMIA was evoked by bolus injection of Escherichia coli endotoxin,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247704,7/11/2014 12:47:56,,1320713596,7/11/2014 12:47:22,instagc,1.0,13763729,USA,"","",75.182.89.225,62,0,,,71,11,ENDOTOXIN,ENDOTOXEMIA,Escherichia coli ENDOTOXIN,45-57-62,0,ENDOTOXEMIA,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia.,62,0,62,0,71,11,1,RO-has_causative_agent,903581,Endotoxemia was evoked by bolus injection of Escherichia coli endotoxin (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram-negative septicemia,endotoxin,Endotoxemia
502247705,7/11/2014 12:06:51,,1320694014,7/11/2014 12:06:39,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:19:16,,1320699352,7/11/2014 12:19:03,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:21:07,,1320700200,7/11/2014 12:20:54,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:29:26,,1320704478,7/11/2014 12:29:09,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.197,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:37:20,,1320708678,7/11/2014 12:36:50,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:37:50,,1320708856,7/11/2014 12:37:29,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:42:44,,1320711177,7/11/2014 12:42:27,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:44:07,,1320711857,7/11/2014 12:43:40,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:49:06,,1320714269,7/11/2014 12:48:50,clixsense,1.0,6344001,AUS,02,Strathfield,60.241.129.81,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,problem DIARRHEA,83-91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247705,7/11/2014 12:49:52,,1320714690,7/11/2014 12:49:33,instagc,1,23149109,USA,NC,Cary,24.206.38.18,91,115,,,99,131,DIARRHEA,CHRONIC DIARRHEA,DIARRHEA,91,115-123,CHRONIC DIARRHEA,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center.,91,115 123,91,115,99,131,-1,RO-has_definitional_manifestation,904722,Ten independent risk factors were evaluated in an effort to identify predictors of problem diarrhea at weaning and chronic diarrhea in infant and juvenile rhesus monkeys (Macaca mulatta) at the California Primate Research Center,diarrhea,chronic diarrhea
502247706,7/11/2014 12:07:00,,1320694083,7/11/2014 12:06:49,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156,NON ALLERGY,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:08:36,,1320694745,7/11/2014 12:08:19,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156-164,NON ALLERGY sufferers,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:09:09,,1320694952,7/11/2014 12:08:38,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156,NON ALLERGY,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:12:46,,1320696616,7/11/2014 12:12:24,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156,NON ALLERGY,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:17:34,,1320698691,7/11/2014 12:16:37,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156,NON ALLERGY,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:21:20,,1320700313,7/11/2014 12:21:03,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156,NON ALLERGY,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:28:01,,1320703807,7/11/2014 12:27:33,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156,NON ALLERGY,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:33:33,,1320706731,7/11/2014 12:32:37,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,115,152,,,122,163,ALLERGY,NON-ALLERGY,"known ALLERGY,",109-115,130-134-149-152-156-164,IgE concentrations in NON ALLERGY sufferers,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:38:23,,1320709188,7/11/2014 12:38:19,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,115,152,,,122,163,ALLERGY,NON-ALLERGY,"volunteers with known ALLERGY, while IgE concentrations",93-104-109-115-124-130-134,130-134-149-152-156-164-174-178,IgE concentrations in NON ALLERGY sufferers did not,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247706,7/11/2014 12:42:26,,1320710980,7/11/2014 12:41:59,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,115,152,,,122,163,ALLERGY,NON-ALLERGY,"ALLERGY,",115,152-156-164,NON ALLERGY sufferers,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change.",115,152 156,115,152,122,163,-1,RO-cause_of,900413,"Acute steady state moderate exercise significantly altered circulating IgE concentrations in volunteers with known allergy, while IgE concentrations in non-allergy sufferers did not change",allergy,non-allergy
502247707,7/11/2014 12:08:20,,1320694645,7/11/2014 12:07:59,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,44,93,,,48,108,MASS,MYELOID SARCOMA,solid MASS of leukemia cells,38-44-49-52-61,93-101-109,MYELOID SARCOMA (chloroma.,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:11:42,,1320696090,7/11/2014 12:11:27,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,44,93,,,48,108,MASS,MYELOID SARCOMA,MASS,44,93-101,MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:17:03,,1320698440,7/11/2014 12:16:51,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,44,93,,,48,108,MASS,MYELOID SARCOMA,a solid MASS of leukemia cells,36-38-44-49-52-61,76-84-90-93-101,granulo cytic or MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:23:54,,1320701416,7/11/2014 12:20:43,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,44,93,,,48,108,MASS,MYELOID SARCOMA,develops a solid MASS of leukemia cells,27-36-38-44-49-52-61,76-84-90-93-101,granulo cytic or MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:24:31,,1320701696,7/11/2014 12:24:23,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,44,93,,,48,108,MASS,MYELOID SARCOMA,develops a solid MASS of leukemia cells,27-36-38-44-49-52-61,76-84-90-93-101,granulo cytic or MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:25:18,,1320701988,7/11/2014 12:25:00,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,44,93,,,48,108,MASS,MYELOID SARCOMA,solid MASS,38-44,93-101,MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:36:18,,1320708223,7/11/2014 12:36:03,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,44,93,,,48,108,MASS,MYELOID SARCOMA,a solid MASS of leukemia cells,36-38-44-49-52-61,93-101,MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:38:08,,1320709065,7/11/2014 12:38:04,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,44,93,,,48,108,MASS,MYELOID SARCOMA,develops a solid MASS of leukemia cells,27-36-38-44-49-52-61,76-84-90-93-101,granulo cytic or MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:39:19,,1320709624,7/11/2014 12:38:32,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,44,93,,,48,108,MASS,MYELOID SARCOMA,solid MASS of leukemia cells,44-49-52-61-38,76-84-90-93-101,granulo cytic or MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247707,7/11/2014 12:40:36,,1320710271,7/11/2014 12:40:11,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,44,93,,,48,108,MASS,MYELOID SARCOMA,solid MASS,44-38,93-101,MYELOID SARCOMA,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma.",44,93 101,44,93,48,108,1,RO-disease_has_finding,901709,"Rarely, a patient with AML develops a solid mass of leukemia cells called a granulo-cytic or myeloid sarcoma (chloroma",mass,myeloid sarcoma
502247708,7/11/2014 12:05:54,,1320693371,7/11/2014 12:05:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS,550,510-522,GLUCOSAMINE sulphate,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:07:50,,1320694461,7/11/2014 12:07:41,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS,550,510,GLUCOSAMINE,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:09:04,,1320694929,7/11/2014 12:08:43,instagc,1.0,19874561,GBR,C3,Saint Ives,80.4.147.13,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS of the knee,550-565-568-572,510-522-531-534-537,GLUCOSAMINE sulphate as an analgesic,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:09:09,,1320694953,7/11/2014 12:08:55,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS,550,510,GLUCOSAMINE,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:12:40,,1320696573,7/11/2014 12:12:13,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,an analgesic OSTEOARTHRITIS of the knee,534-537-550-565-568-572,490-501-507-510-522,controlled trial of GLUCOSAMINE sulphate,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:17:27,,1320698647,7/11/2014 12:17:12,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS,550,510-522,GLUCOSAMINE sulphate,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:20:23,,1320699855,7/11/2014 12:19:24,clixsense,1.0,27812714,NLD,06,Tilburg,84.31.160.155,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,an analgesic in OSTEOARTHRITIS of the knee,534-537-547-550-565-568-572,482-490-501-507-510,placebo controlled trial of GLUCOSAMINE,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:20:23,,1320699869,7/11/2014 12:20:06,prodege,1.0,19192508,USA,OK,Broken Arrow,70.177.111.89,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS of the knee,550-565-568-572,510-522,GLUCOSAMINE sulphate,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:31:38,,1320705666,7/11/2014 12:31:10,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.197,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS,550,510-522,GLUCOSAMINE sulphate,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247708,7/11/2014 12:32:16,,1320706078,7/11/2014 12:31:40,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,550,510,,,564,521,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS of the knee,550-565-572-568,510-522,GLUCOSAMINE sulphate,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and.",550,510,550,510,564,521,1,RO-may_treat,907762,"trial  Lancet  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  New England Journal of Medicine  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis  Osteoarthritis and Cartilage  A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis  Rheumatic Diseases Clinics of North America  Homeopathy and rheumatic disease  Rheumatology (Oxford)  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee  Review  Alternative Medicine Review  Natural treatments for osteoarthritis  Arthritis and",osteoarthritis,glucosamine
502247709,7/11/2014 12:05:24,,1320693142,7/11/2014 12:04:55,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,111,187,TUBERCULIN,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:11:44,,1320696123,7/11/2014 12:11:32,prodege,1.0,15287417,CAN,ON,Mississauga,209.171.47.69,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,111,187-198,TUBERCULIN sensitivity,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:21:36,,1320700407,7/11/2014 12:20:45,sendearnings,1.0,11896941,USA,FL,Seminole,97.106.105.251,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,the diagnosis of TUBERCULOSIS,94-98-108-111,187-198,TUBERCULIN sensitivity,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:28:25,,1320703961,7/11/2014 12:28:09,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,the diagnosis of TUBERCULOSIS shows that the,94-98-108-111-124-130-135,162-171-176-187-198-210-214,subjects with increasing TUBERCULIN sensitivity and those,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:38:50,,1320709369,7/11/2014 12:38:47,inboxpounds,1.0,26876927,GBR,H9,London,81.105.192.192,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,the diagnosis of TUBERCULOSIS shows that the,94-98-108-111-124-130-135,162-171-176-187-198-210-214,subjects with increasing TUBERCULIN sensitivity and those,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:39:31,,1320709750,7/11/2014 12:39:15,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,111,176-187-198,increasing TUBERCULIN sensitivity,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:40:11,,1320710072,7/11/2014 12:39:53,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,111,187-198,TUBERCULIN sensitivity,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:46:18,,1320712803,7/11/2014 12:45:56,instagc,1.0,13763729,USA,"","",75.182.89.225,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,111,187,TUBERCULIN,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:47:39,,1320713483,7/11/2014 12:47:26,superrewards,1.0,25748885,USA,PA,Bloomsburg,96.243.117.187,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,111,187,TUBERCULIN,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247709,7/11/2014 12:49:54,,1320714699,7/11/2014 12:49:37,prizezombie,1.0,19082757,USA,AL,Birmingham,138.26.153.43,111,187,,,123,197,TUBERCULOSIS,TUBERCULIN,the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing tuberculin sensitivity,94-98-108-111-124-130-135-139-144-151-159-162-171-176-187-198,162-171-176-187-198-210-214-220-232-235-241-253-259,subjects with increasing TUBERCULIN sensitivity and those susceptible to acute respiratory virus infections.,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections.,111,187,111,187,123,197,1,RO-may_diagnose,906613,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of tuberculosis shows that the risk groups consist of subjects with increasing tuberculin sensitivity and those susceptible to acute respiratory virus infections,tuberculosis,tuberculin
502247710,7/11/2014 12:03:51,,1320692558,7/11/2014 12:03:37,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,26,HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:06:25,,1320693704,7/11/2014 12:06:12,clixsense,1.0,19162475,GBR,M3,Frome,82.33.126.30,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,26,HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:19:23,,1320699405,7/11/2014 12:18:01,neodev,1,26834562,CAN,ON,Port Dover,24.102.39.105,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,of hypertension nor ELEVATED BLOOD PRESSURE before OC use,81-84-97-101-110-116-125-132-135,26,HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:22:08,,1320700633,7/11/2014 12:21:52,clixsense,1.0,26649250,GBR,N7,Epsom,193.117.31.2,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,26,HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:24:01,,1320701476,7/11/2014 12:23:19,gifthulk,1.0,18659496,CAN,ON,Toronto,198.84.188.216,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,of hypertension nor ELEVATED BLOOD PRESSURE before OC use,81-84-97-101-110-116-125-132-135,3-11-17-26-39-42-50,related blood pressure HYPERTENSION is defined as:,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:42:26,,1320710989,7/11/2014 12:41:10,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,0-2-3-11-17-26,OC - related blood pressure HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:42:49,,1320711222,7/11/2014 12:41:57,neodev,1.0,12115558,USA,OH,Twinsburg,75.187.196.41,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,3-11-17-26,related blood pressure HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:44:30,,1320712015,7/11/2014 12:44:14,fepcrowdflower,1.0,17940235,GBR,X5,Cardiff,176.252.22.6,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,3-11-17-26,related blood pressure HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:44:38,,1320712063,7/11/2014 12:44:20,instagc,1.0,25901556,GBR,C3,Saint Ives,82.9.129.2,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,26,HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
502247710,7/11/2014 12:45:54,,1320712589,7/11/2014 12:45:30,prodege,1.0,1852770,USA,TX,Abilene,76.198.102.54,101,26,,,124,38,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,101-110-116,0-3-17-26-11,OC related blood pressure HYPERTENSION,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,101 110 116,26,101,26,124,38,-1,RO-has_definitional_manifestation,904916,OC-related blood pressure/hypertension is defined as: women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases,elevated blood pressure,hypertension
